{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:51:46Z","timestamp":1770789106061,"version":"3.50.0"},"reference-count":278,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Context.<\/jats:italic>\n                    \u2014Changes in the practice of diagnosing brain tumors are formally reflected in the evolution of the World Health Organization classification. Beyond this classification, the practice of diagnostic pathology is also changing with the availability of new tests and the introduction of new treatment options.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Objective.<\/jats:italic>\n                    \u2014Glioblastomas, oligodendrogliomas, glioneuronal tumors, and primitive pediatric tumors are discussed in an exemplary way to illustrate these changes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Data Sources.<\/jats:italic>\n                    \u2014Review of relevant publications through Medline database searches.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusions.<\/jats:italic>\n                    \u2014The example of glioblastomas shows how new predictive markers may help identify subgroups of tumors that respond to certain therapy regimens. The development of new treatment strategies also leads to different questions in the assessment of brain tumors, as seen in the example of pseudoprogression or the changes in tumor growth pattern in patients taking bevacizumab. Oligodendrogliomas illustrate how the identification of 1p\/19q loss as a cytogenetic aberration aids our understanding of these tumors and changes diagnostic practice but also introduces new challenges in classification. Glioneuronal tumors are an evolving group of lesions. Besides a growing list of usually low-grade entities with well-defined morphologic features, these also include more poorly defined cases in which a component of infiltrating glioma is often associated with focal neuronal elements. The latter is biologically interesting but of uncertain clinical significance. Oligodendrogliomas and glioneuronal tumors both illustrate the importance of effective communication between the pathologist and the treating oncologist in the discussion of these patients. Finally, the discussion of primitive pediatric tumors stresses the clinical importance of the distinction between different entities, like atypical teratoid rhabdoid tumor, \u201ccentral\u201d (supratentorial) primitive neuroectodermal tumor, \u201cperipheral\u201d primitive neuroectodermal tumor, and medulloblastoma. In medulloblastomas, the recognition of different variants is emerging as a prognostic factor that may in the future also predict therapy responsiveness.\n                  <\/jats:p>","DOI":"10.5858\/133.7.1062","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T10:20:49Z","timestamp":1613125249000},"page":"1062-1077","source":"Crossref","is-referenced-by-count":16,"title":["Update on Diagnostic Practice: Tumors of the Nervous System"],"prefix":"10.5858","volume":"133","author":[{"given":"Peter","family":"Pytel","sequence":"first","affiliation":[{"name":"From the Departments of Pathology (Dr Pytel) and Neurology (Dr Lukas), University of Chicago Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimas V.","family":"Lukas","sequence":"additional","affiliation":[{"name":"From the Departments of Pathology (Dr Pytel) and Neurology (Dr Lukas), University of Chicago Medical Center, Chicago, Illinois"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"key":"i1543-2165-133-7-1062-b1","article-title":"WHO Classification of Tumours of the Central Nervous System. 4th ed.","author":"Louis, D. N.","unstructured":"Louis, D. N., H.Ohgaki, O. D.Wiestler, and W. K.Cavenee. WHO Classification of Tumours of the Central Nervous System. 4th ed.Lyon, France: International Agency for Research on Cancer (IARC); 2007."},{"key":"i1543-2165-133-7-1062-b2","series-title":"Childs Nerv Syst","first-page":"477","article-title":"Management of pilocytic astrocytoma with diffuse leptomeningeal spread: two cases and review of the literature.","volume":"21","author":"Aryan, H. E.","year":"2005","unstructured":"Aryan, H. E., H. S.Meltzer, D. C.Lu, B. M.Ozgur, M. L.Levy, and D. A.Bruce. Management of pilocytic astrocytoma with diffuse leptomeningeal spread: two cases and review of the literature.Childs Nerv Syst2005. 21:477\u2013481."},{"key":"i1543-2165-133-7-1062-b3","series-title":"Neuro Oncol","first-page":"188","article-title":"Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.","volume":"5","author":"Hukin, J.","year":"2003","unstructured":"Hukin, J., J.Siffert, H.Cohen, L.Velasquez, D.Zagzag, and J.Allen. Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.Neuro Oncol2003. 5:188\u2013196."},{"key":"i1543-2165-133-7-1062-b4","series-title":"J Clin Neurosci","first-page":"725","article-title":"Spinal leptomeningeal metastases following glioblastoma multiforme treated with radiotherapy.","volume":"9","author":"Lindsay, A.","year":"2002","unstructured":"Lindsay, A., D.Holthouse, P.Robbins, and N.Knuckey. Spinal leptomeningeal metastases following glioblastoma multiforme treated with radiotherapy.J Clin Neurosci2002. 9:725\u2013728."},{"key":"i1543-2165-133-7-1062-b5","series-title":"J Neurooncol","first-page":"227","article-title":"Symptomatic spinal dissemination of malignant astrocytoma.","volume":"61","author":"Saito, R.","year":"2003","unstructured":"Saito, R., T.Kumabe, H.Jokura, R.Shirane, and T.Yoshimoto. Symptomatic spinal dissemination of malignant astrocytoma.J Neurooncol2003. 61:227\u2013235."},{"key":"i1543-2165-133-7-1062-b6","series-title":"Br J Cancer","first-page":"991","article-title":"Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.","volume":"95","author":"Wagner, S.","year":"2006","unstructured":"Wagner, S., M.Benesch, and F.Berthold. et al. Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.Br J Cancer2006. 95:991\u2013997."},{"key":"i1543-2165-133-7-1062-b7","series-title":"Brain Pathol","first-page":"319","article-title":"Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma.","volume":"17","author":"Brat, D. J.","year":"2007","unstructured":"Brat, D. J., B. W.Scheithauer, G. N.Fuller, and T.Tihan. Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma.Brain Pathol2007. 17:319\u2013324."},{"key":"i1543-2165-133-7-1062-b8","series-title":"Brain Pathol","first-page":"304","article-title":"The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.","volume":"17","author":"Fuller, G. N.","year":"2007","unstructured":"Fuller, G. N. and B. W.Scheithauer. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.Brain Pathol2007. 17:304\u2013307."},{"key":"i1543-2165-133-7-1062-b9","series-title":"Acta Neuropathol","first-page":"97","article-title":"The 2007 WHO classification of tumours of the central nervous system.","volume":"114","author":"Louis, D. N.","year":"2007","unstructured":"Louis, D. N., H.Ohgaki, and O. D.Wiestler. et al. The 2007 WHO classification of tumours of the central nervous system.Acta Neuropathol2007. 114:97\u2013109."},{"key":"i1543-2165-133-7-1062-b10","series-title":"Brain Pathol","first-page":"314","article-title":"Papillary tumor of the pineal region and spindle cell oncocytoma of the pituitary: new tumor entities in the 2007 WHO Classification.","volume":"17","author":"Roncaroli, F.","year":"2007","unstructured":"Roncaroli, F. and B. W.Scheithauer. Papillary tumor of the pineal region and spindle cell oncocytoma of the pituitary: new tumor entities in the 2007 WHO Classification.Brain Pathol2007. 17:314\u2013318."},{"key":"i1543-2165-133-7-1062-b11","series-title":"Brain Pathol","first-page":"308","article-title":"The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group.","volume":"17","author":"Rosenblum, M. K.","year":"2007","unstructured":"Rosenblum, M. K.\n          \n          The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group.\n          Brain Pathol\n          2007. 17:308\u2013313."},{"key":"i1543-2165-133-7-1062-b12","series-title":"Arch Pathol Lab Med","first-page":"993","article-title":"Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.","volume":"132","author":"Brat, D. J.","year":"2008","unstructured":"Brat, D. J., J. E.Parisi, and B. K.Kleinschmidt-Demasters. et al. Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.Arch Pathol Lab Med2008. 132:993\u20131007."},{"key":"i1543-2165-133-7-1062-b13","series-title":"Onkologie","first-page":"192","article-title":"Extraneural spread of glioblastoma\u2014 report of two cases.","volume":"31","author":"Templeton, A.","year":"2008","unstructured":"Templeton, A., S.Hofer, and M.Topfer. et al. Extraneural spread of glioblastoma\u2014 report of two cases.Onkologie2008. 31:192\u2013194."},{"key":"i1543-2165-133-7-1062-b14","series-title":"Transplantation","first-page":"340","article-title":"Donors with central nervous system malignancies: are they truly safe?","volume":"76","author":"Buell, J. F.","year":"2003","unstructured":"Buell, J. F., J.Trofe, and G.Sethuraman. et al. Donors with central nervous system malignancies: are they truly safe?Transplantation2003. 76:340\u2013343."},{"key":"i1543-2165-133-7-1062-b15","series-title":"N Engl J Med","first-page":"987","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.","volume":"352","author":"Stupp, R.","year":"2005","unstructured":"Stupp, R., W. P.Mason, and M. J.van den Bent. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med2005. 352:987\u2013996."},{"key":"i1543-2165-133-7-1062-b16","series-title":"Neuro Oncol","first-page":"189","article-title":"A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.","volume":"8","author":"Prados, M. D.","year":"2006","unstructured":"Prados, M. D., K.Lamborn, and W. K.Yung. et al. A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.Neuro Oncol2006. 8:189\u2013193."},{"key":"i1543-2165-133-7-1062-b17","series-title":"Neuro Oncol","first-page":"216","article-title":"Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.","volume":"10","author":"Puduvalli, V. K.","year":"2008","unstructured":"Puduvalli, V. K., P.Giglio, and M. D.Groves. et al. Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.Neuro Oncol2008. 10:216\u2013222."},{"key":"i1543-2165-133-7-1062-b18","series-title":"J Clin Oncol","first-page":"4722","article-title":"Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.","volume":"25","author":"Vredenburgh, J. J.","year":"2007","unstructured":"Vredenburgh, J. J., A.Desjardins, and J. E2ndHerndon. et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.J Clin Oncol2007. 25:4722\u20134729."},{"key":"i1543-2165-133-7-1062-b19","series-title":"Neurology","first-page":"779","article-title":"Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.","volume":"70","author":"Norden, A. D.","year":"2008","unstructured":"Norden, A. D., G. S.Young, and K.Setayesh. et al. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.Neurology2008. 70:779\u2013787."},{"key":"i1543-2165-133-7-1062-b20","series-title":"Clin Cancer Res","first-page":"1931","article-title":"Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.","volume":"2","author":"Yung, W. K.","year":"1996","unstructured":"Yung, W. K., A. P.Kyritsis, M. J.Gleason, and V. A.Levin. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.Clin Cancer Res1996. 2:1931\u20131935."},{"key":"i1543-2165-133-7-1062-b21","series-title":"Neuro Oncol","first-page":"44","article-title":"Primary and secondary glioblastomas: from concept to clinical diagnosis.","volume":"1","author":"Kleihues, P.","year":"1999","unstructured":"Kleihues, P. and H.Ohgaki. Primary and secondary glioblastomas: from concept to clinical diagnosis.Neuro Oncol1999. 1:44\u201351."},{"key":"i1543-2165-133-7-1062-b22","series-title":"Cancer Res","first-page":"159","article-title":"Distinct transcription profiles of primary and secondary glioblastoma subgroups.","volume":"66","author":"Tso, C. L.","year":"2006","unstructured":"Tso, C. L., W. A.Freije, and A.Day. et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups.Cancer Res2006. 66:159\u2013167."},{"key":"i1543-2165-133-7-1062-b23","series-title":"Cancer Biol Ther","first-page":"242","article-title":"Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.","volume":"2","author":"Mischel, P. S.","year":"2003","unstructured":"Mischel, P. S., S. F.Nelson, and T. F.Cloughesy. Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.Cancer Biol Ther2003. 2:242\u2013247."},{"key":"i1543-2165-133-7-1062-b24","series-title":"Mol Cancer Res","first-page":"607","article-title":"Primary glioblastomas express mesenchymal stem-like properties.","volume":"4","author":"Tso, C. L.","year":"2006","unstructured":"Tso, C. L., P.Shintaku, and J.Chen. et al. Primary glioblastomas express mesenchymal stem-like properties.Mol Cancer Res2006. 4:607\u2013619."},{"key":"i1543-2165-133-7-1062-b25","series-title":"Cancer Res","first-page":"11502","article-title":"Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.","volume":"66","author":"Maher, E. A.","year":"2006","unstructured":"Maher, E. A., C.Brennan, and P. Y.Wen. et al. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.Cancer Res2006. 66:11502\u201311513."},{"key":"i1543-2165-133-7-1062-b26","series-title":"Cancer Cell","first-page":"157","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.","volume":"9","author":"Phillips, H. S.","year":"2006","unstructured":"Phillips, H. S., S.Kharbanda, and R.Chen. et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.Cancer Cell2006. 9:157\u2013173."},{"key":"i1543-2165-133-7-1062-b27","series-title":"Am J Pathol","first-page":"425","article-title":"Genetic profile of gliosarcomas.","volume":"156","author":"Reis, R. M.","year":"2000","unstructured":"Reis, R. M., D.Konu-Lebleblicioglu, J. M.Lopes, P.Kleihues, and H.Ohgaki. Genetic profile of gliosarcomas.Am J Pathol2000. 156:425\u2013432."},{"key":"i1543-2165-133-7-1062-b28","series-title":"Lab Invest","first-page":"123","article-title":"Genetic profile of the giant cell glioblastoma.","volume":"79","author":"Peraud, A.","year":"1999","unstructured":"Peraud, A., K.Watanabe, K.Schwechheimer, Y.Yonekawa, P.Kleihues, and H.Ohgaki. Genetic profile of the giant cell glioblastoma.Lab Invest1999. 79:123\u2013129."},{"key":"i1543-2165-133-7-1062-b29","series-title":"Genes Chromosomes Cancer","first-page":"416","article-title":"Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.","volume":"34","author":"Actor, B.","year":"2002","unstructured":"Actor, B., J. M.Cobbers, and R.Buschges. et al. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.Genes Chromosomes Cancer2002. 34:416\u2013427."},{"key":"i1543-2165-133-7-1062-b30","series-title":"J Neuropathol Exp Neurol","first-page":"1","article-title":"Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.","volume":"67","author":"Yip, S.","year":"2008","unstructured":"Yip, S., A. J.Iafrate, and D. N.Louis. Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.J Neuropathol Exp Neurol2008. 67:1\u201315."},{"key":"i1543-2165-133-7-1062-b31","series-title":"Clin Cancer Res","first-page":"378","article-title":"PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors.","volume":"13","author":"Mellinghoff, I. K.","year":"2007","unstructured":"Mellinghoff, I. K., T. F.Cloughesy, and P. S.Mischel. PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors.Clin Cancer Res2007. 13:378\u2013381."},{"key":"i1543-2165-133-7-1062-b32","series-title":"N Engl J Med","first-page":"2012","article-title":"Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.","volume":"353","author":"Mellinghoff, I. K.","year":"2005","unstructured":"Mellinghoff, I. K., M. Y.Wang, and I.Vivanco. et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.N Engl J Med2005. 353:2012\u20132024."},{"key":"i1543-2165-133-7-1062-b33","series-title":"Nat Rev Cancer","first-page":"489","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer.","volume":"2","author":"Vivanco, I.","year":"2002","unstructured":"Vivanco, I. and C. L.Sawyers. The phosphatidylinositol 3-Kinase AKT pathway in human cancer.Nat Rev Cancer2002. 2:489\u2013501."},{"key":"i1543-2165-133-7-1062-b34","series-title":"Clin Cancer Res","first-page":"7841","article-title":"Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.","volume":"11","author":"Lassman, A. B.","year":"2005","unstructured":"Lassman, A. B., M. R.Rossi, and J. J.Raizer. et al. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.Clin Cancer Res2005. 11:7841\u20137850."},{"issue":"2","key":"i1543-2165-133-7-1062-b35","series-title":"J Neurooncol","first-page":"211","article-title":"Epithelial Growth Factor Receptor inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.","volume":"89","author":"Preusser, M.","year":"2008","unstructured":"Preusser, M., E.Gelpi, and A.Rottenfusser. et al. Epithelial Growth Factor Receptor inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.J Neurooncol2008. 892:211\u2013218."},{"key":"i1543-2165-133-7-1062-b36","series-title":"J Natl Cancer Inst","first-page":"880","article-title":"Epidermal growth factor receptor, protein kinase B\/Akt, and glioma response to erlotinib.","volume":"97","author":"Haas-Kogan, D. A.","year":"2005","unstructured":"Haas-Kogan, D. A., M. D.Prados, and T.Tihan. et al. Epidermal growth factor receptor, protein kinase B\/Akt, and glioma response to erlotinib.J Natl Cancer Inst2005. 97:880\u2013887."},{"key":"i1543-2165-133-7-1062-b37","series-title":"Cancer Res","first-page":"7864","article-title":"Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.","volume":"66","author":"Wang, M. Y.","year":"2006","unstructured":"Wang, M. Y., K. V.Lu, and S.Zhu. et al. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.Cancer Res2006. 66:7864\u20137869."},{"key":"i1543-2165-133-7-1062-b38","series-title":"Expert Opin Ther Targets","first-page":"349","article-title":"S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.","volume":"11","author":"Juillerat, A.","year":"2007","unstructured":"Juillerat, A. and L.Juillerat-Jeanneret. S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.Expert Opin Ther Targets2007. 11:349\u2013361."},{"key":"i1543-2165-133-7-1062-b39","series-title":"N Engl J Med","first-page":"997","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma.","volume":"352","author":"Hegi, M. E.","year":"2005","unstructured":"Hegi, M. E., A. C.Diserens, and T.Gorlia. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma.N Engl J Med2005. 352:997\u20131003."},{"key":"i1543-2165-133-7-1062-b40","article-title":"Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.","author":"Preusser, M.","unstructured":"Preusser, M., R. C.Janzer, and J.Felsberg. et al. Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.Brain Pathol. 2008;18(4):520\u2013532."},{"key":"i1543-2165-133-7-1062-b41","series-title":"Neurology","first-page":"535","article-title":"Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.","volume":"63","author":"de Wit, M. C.","year":"2004","unstructured":"de Wit, M. C., H. G.de Bruin, W.Eijkenboom, P. A.Sillevis Smitt, and M. J.van den Bent. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.Neurology2004. 63:535\u2013537."},{"key":"i1543-2165-133-7-1062-b42","series-title":"Lancet Oncol","first-page":"453","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.","volume":"9","author":"Brandsma, D.","year":"2008","unstructured":"Brandsma, D., L.Stalpers, W.Taal, P.Sminia, and M. J.van den Bent. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.Lancet Oncol2008. 9:453\u2013461."},{"issue":"2","key":"i1543-2165-133-7-1062-b43","series-title":"Cancer","first-page":"405","article-title":"Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.","volume":"113","author":"Taal, W.","year":"2008","unstructured":"Taal, W., D.Brandsma, and H. G.de Bruin. et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.Cancer2008. 1132:405\u2013410."},{"key":"i1543-2165-133-7-1062-b44","series-title":"J Neurooncol","first-page":"81","article-title":"Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.","volume":"82","author":"Chamberlain, M. C.","year":"2007","unstructured":"Chamberlain, M. C., M. J.Glantz, L.Chalmers, A.Van Horn, and A. E.Sloan. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.J Neurooncol2007. 82:81\u201383."},{"key":"i1543-2165-133-7-1062-b45","series-title":"Surg Neurol","first-page":"649","article-title":"The effect of bevacizumab (Avastin) on neuroimaging of brain metastases.","volume":"70(6)","author":"Mathews, M. S.","year":"2008","unstructured":"Mathews, M. S., M. E.Linskey, A. N.Hasso, and J. P.Fruehauf. The effect of bevacizumab (Avastin) on neuroimaging of brain metastases.Surg Neurol2008. 70(6):649\u2013652."},{"key":"i1543-2165-133-7-1062-b46","series-title":"J Neurooncol","first-page":"339","article-title":"Time course of imaging changes of GBM during extended bevacizumab treatment.","volume":"88","author":"Ananthnarayan, S.","year":"2008","unstructured":"Ananthnarayan, S., J.Bahng, and J.Roring. et al. Time course of imaging changes of GBM during extended bevacizumab treatment.J Neurooncol2008. 88:339\u2013347."},{"key":"i1543-2165-133-7-1062-b47","series-title":"Science","first-page":"983","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.","volume":"219","author":"Senger, D. R.","year":"1983","unstructured":"Senger, D. R., S. J.Galli, A. M.Dvorak, C. A.Perruzzi, V. S.Harvey, and H. F.Dvorak. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.Science1983. 219:983\u2013985."},{"key":"i1543-2165-133-7-1062-b48","series-title":"Int J Radiat Oncol Biol Phys","first-page":"323","article-title":"Effect of bevacizumab on radiation necrosis of the brain.","volume":"67","author":"Gonzalez, J.","year":"2007","unstructured":"Gonzalez, J., A. J.Kumar, C. A.Conrad, and V. A.Levin. Effect of bevacizumab on radiation necrosis of the brain.Int J Radiat Oncol Biol Phys2007. 67:323\u2013326."},{"key":"i1543-2165-133-7-1062-b49","series-title":"Oncologist","first-page":"165","article-title":"Changing paradigms\u2014an update on the multidisciplinary management of malignant glioma.","volume":"11","author":"Stupp, R.","year":"2006","unstructured":"Stupp, R., M. E.Hegi, and M. J.van den Bent. et al. Changing paradigms\u2014an update on the multidisciplinary management of malignant glioma.Oncologist2006. 11:165\u2013180."},{"key":"i1543-2165-133-7-1062-b50","series-title":"Histopathology","first-page":"437","article-title":"Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.","volume":"37","author":"Cheng, Y.","year":"2000","unstructured":"Cheng, Y., J. C.Pang, and H. K.Ng. et al. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.Histopathology2000. 37:437\u2013444."},{"key":"i1543-2165-133-7-1062-b51","series-title":"Cancer Res","first-page":"6885","article-title":"Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.","volume":"61","author":"Rickman, D. S.","year":"2001","unstructured":"Rickman, D. S., M. P.Bobek, and D. E.Misek. et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.Cancer Res2001. 61:6885\u20136891."},{"key":"i1543-2165-133-7-1062-b52","series-title":"J Neuropathol Exp Neurol","first-page":"769","article-title":"Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.","volume":"65","author":"Addo-Yobo, S. O.","year":"2006","unstructured":"Addo-Yobo, S. O., J.Straessle, A.Anwar, A. M.Donson, B. K.Kleinschmidt-Demasters, and N. K.Foreman. Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.J Neuropathol Exp Neurol2006. 65:769\u2013775."},{"key":"i1543-2165-133-7-1062-b53","series-title":"Cancer","first-page":"1569","article-title":"A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.","volume":"89","author":"Fisher, P. G.","year":"2000","unstructured":"Fisher, P. G., S. N.Breiter, and B. S.Carson. et al. A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.Cancer2000. 89:1569\u20131576."},{"key":"i1543-2165-133-7-1062-b54","series-title":"Neuro Oncol","first-page":"168","article-title":"Pathology of low-grade gliomas: an update of emerging concepts.","volume":"5","author":"Perry, A.","year":"2003","unstructured":"Perry, A.\n          \n          Pathology of low-grade gliomas: an update of emerging concepts.\n          Neuro Oncol\n          2003. 5:168\u2013178."},{"key":"i1543-2165-133-7-1062-b55","series-title":"Spinal Cord","first-page":"282","article-title":"Surgical treatment of intramedullary spinal cord tumors: prognosis and complications.","volume":"46","author":"Nakamura, M.","year":"2008","unstructured":"Nakamura, M., K.Ishii, and K.Watanabe. et al. Surgical treatment of intramedullary spinal cord tumors: prognosis and complications.Spinal Cord2008. 46:282\u2013286."},{"key":"i1543-2165-133-7-1062-b56","series-title":"J Clin Neurosci","first-page":"20","article-title":"Spinal cord gliomas: management and outcome with reference to adjuvant therapy.","volume":"7","author":"Nishio, S.","year":"2000","unstructured":"Nishio, S., T.Morioka, K.Fujii, T.Inamura, and M.Fukui. Spinal cord gliomas: management and outcome with reference to adjuvant therapy.J Clin Neurosci2000. 7:20\u201323."},{"key":"i1543-2165-133-7-1062-b57","series-title":"J Pathol Bacteriol","first-page":"735","article-title":"Oligodendrogliomas of the brain.","volume":"32","author":"Bailey, P.","year":"1929","unstructured":"Bailey, P. and P. C.Bucy. Oligodendrogliomas of the brain.J Pathol Bacteriol1929. 32:735\u2013751."},{"key":"i1543-2165-133-7-1062-b58","series-title":"Nature","first-page":"396","article-title":"Identification of human brain tumour initiating cells.","volume":"432","author":"Singh, S. K.","year":"2004","unstructured":"Singh, S. K., C.Hawkins, and I. D.Clarke. et al. Identification of human brain tumour initiating cells.Nature2004. 432:396\u2013401."},{"key":"i1543-2165-133-7-1062-b59","series-title":"J Neuropathol Exp Neurol","first-page":"947","article-title":"Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.","volume":"61","author":"Perry, A.","year":"2002","unstructured":"Perry, A., B. W.Scheithauer, R. J.Macaulay, C.Raffel, K. A.Roth, and J. M.Kros. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.J Neuropathol Exp Neurol2002. 61:947\u2013955."},{"key":"i1543-2165-133-7-1062-b60","series-title":"Arch Pathol Lab Med","first-page":"1532","article-title":"Frozen section discrepancy in the evaluation of central nervous system tumors.","volume":"131","author":"Plesec, T. P.","year":"2007","unstructured":"Plesec, T. P. and R. A.Prayson. Frozen section discrepancy in the evaluation of central nervous system tumors.Arch Pathol Lab Med2007. 131:1532\u20131540."},{"key":"i1543-2165-133-7-1062-b61","series-title":"Semin Diagn Pathol","first-page":"251","article-title":"Oligodendroglioma: diagnosis and prognosis.","volume":"4","author":"Bruner, J. M.","year":"1987","unstructured":"Bruner, J. M.\n          \n          Oligodendroglioma: diagnosis and prognosis.\n          Semin Diagn Pathol\n          1987. 4:251\u2013261."},{"key":"i1543-2165-133-7-1062-b62","series-title":"Neurosurgery","first-page":"1279","article-title":"Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.","volume":"45","author":"Fortin, D.","year":"1999","unstructured":"Fortin, D., G. J.Cairncross, and R. R.Hammond. Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.Neurosurgery1999. 45:1279\u20131291."},{"key":"i1543-2165-133-7-1062-b63","series-title":"Cancer","first-page":"1381","article-title":"Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas.","volume":"79","author":"Coons, S. W.","year":"1997","unstructured":"Coons, S. W., P. C.Johnson, B. W.Scheithauer, A. J.Yates, and D. K.Pearl. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas.Cancer1997. 79:1381\u20131393."},{"key":"i1543-2165-133-7-1062-b64","series-title":"Adv Anat Pathol","first-page":"183","article-title":"Oligodendroglial neoplasms: current concepts, misconceptions, and folklore.","volume":"8","author":"Perry, A.","year":"2001","unstructured":"Perry, A.\n          \n          Oligodendroglial neoplasms: current concepts, misconceptions, and folklore.\n          Adv Anat Pathol\n          2001. 8:183\u2013199."},{"key":"i1543-2165-133-7-1062-b65","series-title":"Neurosurgery","first-page":"878","article-title":"The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.","volume":"41","author":"Coons, S. W.","year":"1997","unstructured":"Coons, S. W., P. C.Johnson, and D. K.Pearl. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.Neurosurgery1997. 41:878\u2013884."},{"key":"i1543-2165-133-7-1062-b66","series-title":"Cancer","first-page":"1107","article-title":"Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.","volume":"78","author":"Kros, J. M.","year":"1996","unstructured":"Kros, J. M., W. C.Hop, J. J.Godschalk, and K. K.Krishnadath. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.Cancer1996. 78:1107\u20131113."},{"key":"i1543-2165-133-7-1062-b67","series-title":"Cancer","first-page":"1345","article-title":"Clinicopathologic correlations in the oligodendroglioma.","volume":"59","author":"Burger, P. C.","year":"1987","unstructured":"Burger, P. C., C. E.Rawlings, E. B.Cox, R. E.McLendon, S. C. JrSchold, and D. E.Bullard. Clinicopathologic correlations in the oligodendroglioma.Cancer1987. 59:1345\u20131352."},{"key":"i1543-2165-133-7-1062-b68","series-title":"Cancer","first-page":"2107","article-title":"Grading of oligodendrogliomas.","volume":"52","author":"Smith, M. T.","year":"1983","unstructured":"Smith, M. T., C. L.Ludwig, A. D.Godfrey, and V. W.Armbrustmacher. Grading of oligodendrogliomas.Cancer1983. 52:2107\u20132114."},{"key":"i1543-2165-133-7-1062-b69","series-title":"J Neuropathol Exp Neurol","first-page":"65","article-title":"Oligodendroglioma. Histologic evaluation and prognosis.","volume":"45","author":"Mork, S. J.","year":"1986","unstructured":"Mork, S. J., T. B.Halvorsen, K. F.Lindegaard, and G. E.Eide. Oligodendroglioma. Histologic evaluation and prognosis.J Neuropathol Exp Neurol1986. 45:65\u201378."},{"key":"i1543-2165-133-7-1062-b70","series-title":"J Clin Oncol","first-page":"5419","article-title":"Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.","volume":"24","author":"Miller, C. R.","year":"2006","unstructured":"Miller, C. R., C. P.Dunham, B. W.Scheithauer, and A.Perry. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.J Clin Oncol2006. 24:5419\u20135426."},{"key":"i1543-2165-133-7-1062-b71","series-title":"Brain Pathol","first-page":"360","article-title":"Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.","volume":"18","author":"Giannini, C.","year":"2008","unstructured":"Giannini, C., P. C.Burger, and B. A.Berkey. et al. Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.Brain Pathol2008. 18:360\u2013369."},{"key":"i1543-2165-133-7-1062-b72","series-title":"J Neuropathol Exp Neurol","first-page":"545","article-title":"Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p\/19q loss, and correlations with outcome.","volume":"66","author":"Kros, J. M.","year":"2007","unstructured":"Kros, J. M., T.Gorlia, and M. C.Kouwenhoven. et al. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p\/19q loss, and correlations with outcome.J Neuropathol Exp Neurol2007. 66:545\u2013551."},{"key":"i1543-2165-133-7-1062-b73","series-title":"J Neuropathol Exp Neurol","first-page":"988","article-title":"Identification of der(1;19)(q10; p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.","volume":"65","author":"Griffin, C. A.","year":"2006","unstructured":"Griffin, C. A., P.Burger, and L.Morsberger. et al. Identification of der(1;19)(q10; p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.J Neuropathol Exp Neurol2006. 65:988\u2013994."},{"key":"i1543-2165-133-7-1062-b74","series-title":"Cancer Res","first-page":"9852","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.","volume":"66","author":"Jenkins, R. B.","year":"2006","unstructured":"Jenkins, R. B., H.Blair, and K. V.Ballman. et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.Cancer Res2006. 66:9852\u20139861."},{"key":"i1543-2165-133-7-1062-b75","series-title":"Clin Cancer Res","first-page":"1119","article-title":"Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.","volume":"11","author":"Barbashina, V.","year":"2005","unstructured":"Barbashina, V., P.Salazar, E. C.Holland, M. K.Rosenblum, and M.Ladanyi. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res2005. 11:1119\u20131128."},{"key":"i1543-2165-133-7-1062-b76","series-title":"Brain Pathol","first-page":"121","article-title":"Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p\/19q status with survival.","volume":"14","author":"Felsberg, J.","year":"2004","unstructured":"Felsberg, J., A.Erkwoh, and M. C.Sabel. et al. Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p\/19q status with survival.Brain Pathol2004. 14:121\u2013130."},{"key":"i1543-2165-133-7-1062-b77","series-title":"Int J Cancer","first-page":"792","article-title":"Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.","volume":"119","author":"Tews, B.","year":"2006","unstructured":"Tews, B., J.Felsberg, and C.Hartmann. et al. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.Int J Cancer2006. 119:792\u2013800."},{"key":"i1543-2165-133-7-1062-b78","series-title":"J Natl Cancer Inst","first-page":"1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.","volume":"90","author":"Cairncross, J. G.","year":"1998","unstructured":"Cairncross, J. G., K.Ueki, and M. C.Zlatescu. et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.J Natl Cancer Inst1998. 90:1473\u20131479."},{"key":"i1543-2165-133-7-1062-b79","series-title":"Cancer","first-page":"1276","article-title":"Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.","volume":"97","author":"van den Bent, M. J.","year":"2003","unstructured":"van den Bent, M. J., L. H.Looijenga, and K.Langenberg. et al. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.Cancer2003. 97:1276\u20131284."},{"key":"i1543-2165-133-7-1062-b80","series-title":"Arch Pathol Lab Med","first-page":"242","article-title":"Clinicopathologic aspects of 1p\/19q loss and the diagnosis of oligodendroglioma.","volume":"131","author":"Aldape, K.","year":"2007","unstructured":"Aldape, K., P. C.Burger, and A.Perry. Clinicopathologic aspects of 1p\/19q loss and the diagnosis of oligodendroglioma.Arch Pathol Lab Med2007. 131:242\u2013251."},{"key":"i1543-2165-133-7-1062-b81","series-title":"J Clin Oncol","first-page":"636","article-title":"Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.","volume":"18","author":"Smith, J. S.","year":"2000","unstructured":"Smith, J. S., A.Perry, and T. J.Borell. et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.J Clin Oncol2000. 18:636\u2013645."},{"key":"i1543-2165-133-7-1062-b82","series-title":"J Neurooncol","first-page":"293","article-title":"Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.","volume":"88","author":"Iwamoto, F. M.","year":"2008","unstructured":"Iwamoto, F. M., L.Nicolardi, and A.Demopoulos. et al. Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.J Neurooncol2008. 88:293\u2013298."},{"key":"i1543-2165-133-7-1062-b83","series-title":"J Clin Oncol","first-page":"2707","article-title":"Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.","volume":"24","author":"Cairncross, G.","year":"2006","unstructured":"Cairncross, G., B.Berkey, and E.Shaw. et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.J Clin Oncol2006. 24:2707\u20132714."},{"key":"i1543-2165-133-7-1062-b84","series-title":"J Clin Oncol","first-page":"2715","article-title":"Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.","volume":"24","author":"van den Bent, M. J.","year":"2006","unstructured":"van den Bent, M. J., A. F.Carpentier, and A. A.Brandes. et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.J Clin Oncol2006. 24:2715\u20132722."},{"key":"i1543-2165-133-7-1062-b85","series-title":"Can J Neurol Sci","first-page":"215","article-title":"PCV for oligodendroglial tumors: in search of prognostic factors for response and survival.","volume":"28","author":"Fortin, D.","year":"2001","unstructured":"Fortin, D., D. R.Macdonald, L.Stitt, and J. G.Cairncross. PCV for oligodendroglial tumors: in search of prognostic factors for response and survival.Can J Neurol Sci2001. 28:215\u2013223."},{"key":"i1543-2165-133-7-1062-b86","series-title":"J Neurooncol","first-page":"267","article-title":"Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.","volume":"61","author":"Chahlavi, A.","year":"2003","unstructured":"Chahlavi, A., A.Kanner, D.Peereboom, S. M.Staugaitis, P.Elson, and G.Barnett. Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.J Neurooncol2003. 61:267\u2013273."},{"key":"i1543-2165-133-7-1062-b87","series-title":"Eur J Cancer","first-page":"2499","article-title":"1p\/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.","volume":"42","author":"Kouwenhoven, M. C.","year":"2006","unstructured":"Kouwenhoven, M. C., J. M.Kros, and P. J.French. et al. 1p\/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.Eur J Cancer2006. 42:2499\u20132503."},{"key":"i1543-2165-133-7-1062-b88","series-title":"Neurology","first-page":"1831","article-title":"Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome.","volume":"68","author":"Kaloshi, G.","year":"2007","unstructured":"Kaloshi, G., A.Benouaich-Amiel, and F.Diakite. et al. Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome.Neurology2007. 68:1831\u20131836."},{"key":"i1543-2165-133-7-1062-b89","series-title":"Ann Oncol","first-page":"942","article-title":"Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide.","volume":"16","author":"Brada, M.","year":"2005","unstructured":"Brada, M., S.Ashley, and A.Dowe. et al. Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide.Ann Oncol2005. 16:942\u2013949."},{"key":"i1543-2165-133-7-1062-b90","series-title":"Clin Cancer Res","first-page":"6933","article-title":"Combined 1p\/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?","volume":"13","author":"Weller, M.","year":"2007","unstructured":"Weller, M., H.Berger, and C.Hartmann. et al. Combined 1p\/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?Clin Cancer Res2007. 13:6933\u20136937."},{"key":"i1543-2165-133-7-1062-b91","series-title":"Neurosurgery","first-page":"545","article-title":"Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.","volume":"23","author":"Daumas-Duport, C.","year":"1988","unstructured":"Daumas-Duport, C., B. W.Scheithauer, J. P.Chodkiewicz, E. R. JrLaws, and C.Vedrenne. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.Neurosurgery1988. 23:545\u2013556."},{"key":"i1543-2165-133-7-1062-b92","series-title":"Cancer","first-page":"989","article-title":"Ganglioglioma: an ultrastructural and immunohistochemical study.","volume":"79","author":"Hirose, T.","year":"1997","unstructured":"Hirose, T., B. W.Scheithauer, M. B.Lopes, H. A.Gerber, H. J.Altermatt, and S. R.VandenBerg. Ganglioglioma: an ultrastructural and immunohistochemical study.Cancer1997. 79:989\u20131003."},{"key":"i1543-2165-133-7-1062-b93","series-title":"Acta Neuropathol","first-page":"166","article-title":"Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases.","volume":"88","author":"Wolf, H. K.","year":"1994","unstructured":"Wolf, H. K., M. B.Muller, M.Spanle, J.Zentner, J.Schramm, and O. D.Wiestler. Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases.Acta Neuropathol1994. 88:166\u2013173."},{"key":"i1543-2165-133-7-1062-b94","series-title":"J Neurosurg","first-page":"58","article-title":"Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential (\u201cdesmoplastic infantile gangliogliomas\u201d). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis.","volume":"66","author":"VandenBerg, S. R.","year":"1987","unstructured":"VandenBerg, S. R., E. E.May, and L. J.Rubinstein. et al. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential (\u201cdesmoplastic infantile gangliogliomas\u201d). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis.J Neurosurg1987. 66:58\u201371."},{"key":"i1543-2165-133-7-1062-b95","series-title":"Arch Pathol Lab Med","first-page":"228","article-title":"Mixed glioneuronal tumors: recently described entities.","volume":"131","author":"Edgar, M. A.","year":"2007","unstructured":"Edgar, M. A. and M. K.Rosenblum. Mixed glioneuronal tumors: recently described entities.Arch Pathol Lab Med2007. 131:228\u2013233."},{"key":"i1543-2165-133-7-1062-b96","series-title":"Am J Surg Pathol","first-page":"582","article-title":"A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor?","volume":"26","author":"Komori, T.","year":"2002","unstructured":"Komori, T., B. W.Scheithauer, and T.Hirose. A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor?Am J Surg Pathol2002. 26:582\u2013591."},{"key":"i1543-2165-133-7-1062-b97","series-title":"Am J Surg Pathol","first-page":"1171","article-title":"Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm.","volume":"22","author":"Komori, T.","year":"1998","unstructured":"Komori, T., B. W.Scheithauer, and D. C.Anthony. et al. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm.Am J Surg Pathol1998. 22:1171\u20131183."},{"key":"i1543-2165-133-7-1062-b98","series-title":"Am J Surg Pathol","first-page":"502","article-title":"A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including \u201crosetted\u201d) islands: report of 4 cases.","volume":"23","author":"Teo, J. G.","year":"1999","unstructured":"Teo, J. G., S. H.Gultekin, M.Bilsky, P.Gutin, and M. K.Rosenblum. A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including \u201crosetted\u201d) islands: report of 4 cases.Am J Surg Pathol1999. 23:502\u2013510."},{"key":"i1543-2165-133-7-1062-b99","series-title":"Am J Surg Pathol","first-page":"1196","article-title":"Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p\/19q deletion analysis.","volume":"31","author":"Barbashina, V.","year":"2007","unstructured":"Barbashina, V., P.Salazar, M.Ladanyi, M. K.Rosenblum, and M. A.Edgar. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p\/19q deletion analysis.Am J Surg Pathol2007. 31:1196\u20131202."},{"key":"i1543-2165-133-7-1062-b100","series-title":"J Neurosurg","first-page":"1055","article-title":"Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. Case report.","volume":"84","author":"Sasaki, A.","year":"1996","unstructured":"Sasaki, A., J.Hirato, Y.Nakazato, M.Tamura, and H.Kadowaki. Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. Case report.J Neurosurg1996. 84:1055\u20131059."},{"key":"i1543-2165-133-7-1062-b101","series-title":"Pediatr Neurosurg","first-page":"132","article-title":"Malignant glial tumor arising from the site of a previous hamartoma\/ganglioglioma: coincidence or malignant transformation?","volume":"30","author":"Mittler, M. A.","year":"1999","unstructured":"Mittler, M. A., B. C.Walters, A. H.Fried, E. A.Sotomayor, and E. G.Stopa. Malignant glial tumor arising from the site of a previous hamartoma\/ganglioglioma: coincidence or malignant transformation?Pediatr Neurosurg1999. 30:132\u2013134."},{"key":"i1543-2165-133-7-1062-b102","series-title":"Pediatr Neurosurg","first-page":"301","article-title":"Oligodendroglial ganglioglioma with anaplastic features arising from the thalamus.","volume":"34","author":"Johnson, M. D.","year":"2001","unstructured":"Johnson, M. D., M. T.Jennings, and S. T.Toms. Oligodendroglial ganglioglioma with anaplastic features arising from the thalamus.Pediatr Neurosurg2001. 34:301\u2013305."},{"key":"i1543-2165-133-7-1062-b103","series-title":"Cancer","first-page":"146","article-title":"Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.","volume":"101","author":"Luyken, C.","year":"2004","unstructured":"Luyken, C., I.Blumcke, R.Fimmers, H.Urbach, O. D.Wiestler, and J.Schramm. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.Cancer2004. 101:146\u2013155."},{"key":"i1543-2165-133-7-1062-b104","series-title":"Ann Diagn Pathol","first-page":"240","article-title":"Malignant transformation of a dysembryoplastic neuroepithelial tumor after radiation and chemotherapy.","volume":"7","author":"Rushing, E. J.","year":"2003","unstructured":"Rushing, E. J., L. D.Thompson, and H.Mena. Malignant transformation of a dysembryoplastic neuroepithelial tumor after radiation and chemotherapy.Ann Diagn Pathol2003. 7:240\u2013244."},{"key":"i1543-2165-133-7-1062-b105","series-title":"Cancer","first-page":"2862","article-title":"Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis.","volume":"73","author":"Jay, V.","year":"1994","unstructured":"Jay, V., J.Squire, L. E.Becker, and R.Humphreys. Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis.Cancer1994. 73:2862\u20132868."},{"key":"i1543-2165-133-7-1062-b106","series-title":"Clin Neurol Neurosurg","first-page":"761","article-title":"Ganglioglioma with anaplastic recurrence of the neuronal element following radiotherapy.","volume":"108","author":"Tarnaris, A.","year":"2006","unstructured":"Tarnaris, A., C.O'Brien, and R. M.Redfern. Ganglioglioma with anaplastic recurrence of the neuronal element following radiotherapy.Clin Neurol Neurosurg2006. 108:761\u2013767."},{"key":"i1543-2165-133-7-1062-b107","series-title":"Neuropathology","first-page":"463","article-title":"Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components.","volume":"27","author":"Mittelbronn, M.","year":"2007","unstructured":"Mittelbronn, M., J.Schittenhelm, and D.Lemke. et al. Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components.Neuropathology2007. 27:463\u2013467."},{"key":"i1543-2165-133-7-1062-b108","series-title":"Pediatr Dev Pathol","first-page":"582","article-title":"Desmoplastic infantile ganglioglioma.","volume":"2","author":"Craver, R. D.","year":"1999","unstructured":"Craver, R. D., J.Nadell, and J. S.Nelson. Desmoplastic infantile ganglioglioma.Pediatr Dev Pathol1999. 2:582\u2013587."},{"key":"i1543-2165-133-7-1062-b109","series-title":"Surg Neurol","first-page":"304","article-title":"Desmoplastic infantile ganglioglioma: novel aspects in clinical presentation and genetics.","volume":"68","author":"Lonnrot, K.","year":"2007","unstructured":"Lonnrot, K., M.Terho, V.Kahara, H.Haapasalo, and P.Helen. Desmoplastic infantile ganglioglioma: novel aspects in clinical presentation and genetics.Surg Neurol2007. 68:304\u2013308."},{"key":"i1543-2165-133-7-1062-b110","series-title":"J Neurosurg Pediatrics","first-page":"95","article-title":"Desmoplastic infantile ganglioglioma with a malignant course.","volume":"1","author":"Hoving, E. W.","year":"2008","unstructured":"Hoving, E. W., J. M.Kros, E.Groninger, and W. F.den Dunnen. Desmoplastic infantile ganglioglioma with a malignant course.J Neurosurg Pediatrics2008. 1:95\u201398."},{"key":"i1543-2165-133-7-1062-b111","series-title":"Histopathology","first-page":"887","article-title":"Neuronal features of oligodendrogliomas\u2014an ultrastructural and immunohistochemical study.","volume":"50","author":"Vyberg, M.","year":"2007","unstructured":"Vyberg, M., B. P.Ulhoi, and P. S.Teglbjaerg. Neuronal features of oligodendrogliomas\u2014an ultrastructural and immunohistochemical study.Histopathology2007. 50:887\u2013896."},{"key":"i1543-2165-133-7-1062-b112","series-title":"Neuropathol Appl Neurobiol","first-page":"302","article-title":"Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study.","volume":"24","author":"Wharton, S. B.","year":"1998","unstructured":"Wharton, S. B., K. K.Chan, F. A.Hamilton, and J. R.Anderson. Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study.Neuropathol Appl Neurobiol1998. 24:302\u2013308."},{"key":"i1543-2165-133-7-1062-b113","series-title":"Acta Neuropathol","first-page":"313","article-title":"Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.","volume":"113","author":"Rodriguez, F. J.","year":"2007","unstructured":"Rodriguez, F. J., B. W.Scheithauer, and P. D.Robbins. et al. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.Acta Neuropathol2007. 113:313\u2013324."},{"key":"i1543-2165-133-7-1062-b114","series-title":"Acta Neuropathol","first-page":"194","article-title":"Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study.","volume":"89","author":"Kordek, R.","year":"1995","unstructured":"Kordek, R., W.Biernat, W.Sapieja, J.Alwasiak, and P. P.Liberski. Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study.Acta Neuropathol1995. 89:194\u2013197."},{"key":"i1543-2165-133-7-1062-b115","series-title":"Am J Surg Pathol","first-page":"80","article-title":"Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors.","volume":"20","author":"Powell, S. Z.","year":"1996","unstructured":"Powell, S. Z., A. T.Yachnis, L. B.Rorke, A. M.Rojiani, and T. A.Eskin. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors.Am J Surg Pathol1996. 20:80\u201385."},{"key":"i1543-2165-133-7-1062-b116","article-title":"Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.","author":"Perry, A.","unstructured":"Perry, A., C. R.Miller, and M.Gujrati. et al. Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.Brain Pathol. 2009;19(1):81\u201390."},{"key":"i1543-2165-133-7-1062-b117","series-title":"Virchows Arch","first-page":"665","article-title":"Secondary glioblastoma with advanced neuronal immunophenotype.","volume":"447","author":"Shibahara, J.","year":"2005","unstructured":"Shibahara, J. and M.Fukayama. Secondary glioblastoma with advanced neuronal immunophenotype.Virchows Arch2005. 447:665\u2013668."},{"key":"i1543-2165-133-7-1062-b118","series-title":"Ann Diagn Pathol","first-page":"387","article-title":"Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems.","volume":"7","author":"Vogel, H.","year":"2003","unstructured":"Vogel, H. and G. N.Fuller. Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems.Ann Diagn Pathol2003. 7:387\u2013398."},{"key":"i1543-2165-133-7-1062-b119","series-title":"Annu Rev Pathol","first-page":"341","article-title":"The origins of medulloblastoma subtypes.","volume":"3","author":"Gilbertson, R. J.","year":"2008","unstructured":"Gilbertson, R. J. and D. W.Ellison. The origins of medulloblastoma subtypes.Annu Rev Pathol2008. 3:341\u2013365."},{"key":"i1543-2165-133-7-1062-b120","series-title":"Nature","first-page":"436","article-title":"Prediction of central nervous system embryonal tumour outcome based on gene expression.","volume":"415","author":"Pomeroy, S. L.","year":"2002","unstructured":"Pomeroy, S. L., P.Tamayo, and M.Gaasenbeek. et al. Prediction of central nervous system embryonal tumour outcome based on gene expression.Nature2002. 415:436\u2013442."},{"key":"i1543-2165-133-7-1062-b121","series-title":"Oncol Rep","first-page":"1341","article-title":"PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.","volume":"12","author":"Inda, M. M.","year":"2004","unstructured":"Inda, M. M., J.Mercapide, and J.Munoz. et al. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.Oncol Rep2004. 12:1341\u20131347."},{"key":"i1543-2165-133-7-1062-b122","series-title":"Brain Pathol","first-page":"276","article-title":"Congenital glioblastoma: a clinicopathologic and genetic analysis.","volume":"17","author":"Brat, D. J.","year":"2007","unstructured":"Brat, D. J., B. M.Shehata, and A. A.Castellano-Sanchez. et al. Congenital glioblastoma: a clinicopathologic and genetic analysis.Brain Pathol2007. 17:276\u2013281."},{"key":"i1543-2165-133-7-1062-b123","series-title":"Expert Rev Anticancer Ther","first-page":"S51","article-title":"Spectrum of pediatric gliomas: implications for the development of future therapies.","volume":"7","author":"Pytel, P.","year":"2007","unstructured":"Pytel, P.\n          \n          Spectrum of pediatric gliomas: implications for the development of future therapies.\n          Expert Rev Anticancer Ther\n          2007. 7:S51\u2013S60."},{"key":"i1543-2165-133-7-1062-b124","series-title":"J Clin Oncol","first-page":"971","article-title":"Biologic risk stratification of medulloblastoma: the real time is now.","volume":"22","author":"Fisher, P. G.","year":"2004","unstructured":"Fisher, P. G., P. C.Burger, and C. G.Eberhart. Biologic risk stratification of medulloblastoma: the real time is now.J Clin Oncol2004. 22:971\u2013974."},{"key":"i1543-2165-133-7-1062-b125","series-title":"Neurol Clin","first-page":"897","article-title":"Pediatric brain tumors.","volume":"21","author":"Ullrich, N. J.","year":"2003","unstructured":"Ullrich, N. J. and S. L.Pomeroy. Pediatric brain tumors.Neurol Clin2003. 21:897\u2013913."},{"key":"i1543-2165-133-7-1062-b126","series-title":"J Clin Oncol","first-page":"994","article-title":"Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas.","volume":"22","author":"Fernandez-Teijeiro, A.","year":"2004","unstructured":"Fernandez-Teijeiro, A., R. A.Betensky, L. M.Sturla, J. Y.Kim, P.Tamayo, and S. L.Pomeroy. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas.J Clin Oncol2004. 22:994\u2013998."},{"key":"i1543-2165-133-7-1062-b127","series-title":"J Clin Oncol","first-page":"984","article-title":"Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.","volume":"22","author":"Gajjar, A.","year":"2004","unstructured":"Gajjar, A., R.Hernan, and M.Kocak. et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.J Clin Oncol2004. 22:984\u2013993."},{"key":"i1543-2165-133-7-1062-b128","series-title":"Cancer","first-page":"552","article-title":"Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.","volume":"94","author":"Eberhart, C. G.","year":"2002","unstructured":"Eberhart, C. G., J. L.Kepner, and P. T.Goldthwaite. et al. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.Cancer2002. 94:552\u2013560."},{"key":"i1543-2165-133-7-1062-b129","series-title":"J Neuropathol Exp Neurol","first-page":"441","article-title":"Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.","volume":"63","author":"Eberhart, C. G.","year":"2004","unstructured":"Eberhart, C. G., J.Kratz, and Y.Wang. et al. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.J Neuropathol Exp Neurol2004. 63:441\u2013449."},{"key":"i1543-2165-133-7-1062-b130","series-title":"N Engl J Med","first-page":"906","article-title":"Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain.","volume":"321","author":"Biegel, J. A.","year":"1989","unstructured":"Biegel, J. A., L. B.Rorke, and B. S.Emanuel. Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain.N Engl J Med1989. 321:906."},{"key":"i1543-2165-133-7-1062-b131","series-title":"J Neurosurg","first-page":"710","article-title":"Monosomy 22 in rhabdoid or atypical tumors of the brain.","volume":"73","author":"Biegel, J. A.","year":"1990","unstructured":"Biegel, J. A., L. B.Rorke, R. J.Packer, and B. S.Emanuel. Monosomy 22 in rhabdoid or atypical tumors of the brain.J Neurosurg1990. 73:710\u2013714."},{"key":"i1543-2165-133-7-1062-b132","series-title":"Am J Surg Pathol","first-page":"1083","article-title":"Atypical teratoid\/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.","volume":"22","author":"Burger, P. C.","year":"1998","unstructured":"Burger, P. C., I. T.Yu, and T.Tihan. et al. Atypical teratoid\/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.Am J Surg Pathol1998. 22:1083\u20131092."},{"key":"i1543-2165-133-7-1062-b133","series-title":"Ultrastruct Pathol","first-page":"369","article-title":"Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood.","volume":"21","author":"Bhattacharjee, M.","year":"1997","unstructured":"Bhattacharjee, M., J.Hicks, and L.Langford. et al. Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood.Ultrastruct Pathol1997. 21:369\u2013378."},{"key":"i1543-2165-133-7-1062-b134","series-title":"Clin Cancer Res","first-page":"2759","article-title":"Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.","volume":"6","author":"Biegel, J. A.","year":"2000","unstructured":"Biegel, J. A., B.Fogelgren, and J. Y.Zhou. et al. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.Clin Cancer Res2000. 6:2759\u20132763."},{"key":"i1543-2165-133-7-1062-b135","series-title":"Am J Surg Pathol","first-page":"644","article-title":"Immunohistochemical analysis of hSNF5\/INI1 in pediatric CNS neoplasms.","volume":"28","author":"Judkins, A. R.","year":"2004","unstructured":"Judkins, A. R., J.Mauger, A.Ht, L. B.Rorke, and J. A.Biegel. Immunohistochemical analysis of hSNF5\/INI1 in pediatric CNS neoplasms.Am J Surg Pathol2004. 28:644\u2013650."},{"key":"i1543-2165-133-7-1062-b136","series-title":"Expert Rev Anticancer Ther","first-page":"907","article-title":"Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges.","volume":"5","author":"Strother, D.","year":"2005","unstructured":"Strother, D.\n          \n          Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges.\n          Expert Rev Anticancer Ther\n          2005. 5:907\u2013915."},{"key":"i1543-2165-133-7-1062-b137","series-title":"Diagn Mol Pathol","first-page":"108","article-title":"Primary Ewing sarcoma of the brain: a case report and literature review.","volume":"16","author":"Kazmi, S. A.","year":"2007","unstructured":"Kazmi, S. A., A.Perry, J. G.Pressey, J. C.Wellons, Y.Hammers, and C. A.Palmer. Primary Ewing sarcoma of the brain: a case report and literature review.Diagn Mol Pathol2007. 16:108\u2013111."},{"key":"i1543-2165-133-7-1062-b138","series-title":"Hum Pathol","first-page":"845","article-title":"Peripheral primitive neuroectodermal tumor\/Ewing's sarcoma of the craniospinal vault: case reports and review.","volume":"37","author":"Mobley, B. C.","year":"2006","unstructured":"Mobley, B. C., D.Roulston, G. V.Shah, K. E.Bijwaard, and P. E.McKeever. Peripheral primitive neuroectodermal tumor\/Ewing's sarcoma of the craniospinal vault: case reports and review.Hum Pathol2006. 37:845\u2013853."},{"key":"i1543-2165-133-7-1062-b139","series-title":"J Neurooncol","first-page":"65","article-title":"Primitive neuroectodermal tumours (PNETs) located in the spinal canal; the relevance of classification as central or peripheral PNET: case report of a primary spinal PNET occurrence with a critical literature review.","volume":"77","author":"Kampman, W. A.","year":"2006","unstructured":"Kampman, W. A., J. M.Kros, T. H.De Jong, and M. H.Lequin. Primitive neuroectodermal tumours (PNETs) located in the spinal canal; the relevance of classification as central or peripheral PNET: case report of a primary spinal PNET occurrence with a critical literature review.J Neurooncol2006. 77:65\u201372."},{"key":"i1543-2165-133-7-1062-b1","article-title":"WHO Classification of Tumours of the Central Nervous System. 4th ed.","author":"Louis, D. N.","unstructured":"Louis, D. N., H.Ohgaki, O. D.Wiestler, and W. K.Cavenee. WHO Classification of Tumours of the Central Nervous System. 4th ed.Lyon, France: International Agency for Research on Cancer (IARC); 2007."},{"key":"i1543-2165-133-7-1062-b2","series-title":"Childs Nerv Syst","first-page":"477","article-title":"Management of pilocytic astrocytoma with diffuse leptomeningeal spread: two cases and review of the literature.","volume":"21","author":"Aryan, H. E.","year":"2005","unstructured":"Aryan, H. E., H. S.Meltzer, D. C.Lu, B. M.Ozgur, M. L.Levy, and D. A.Bruce. Management of pilocytic astrocytoma with diffuse leptomeningeal spread: two cases and review of the literature.Childs Nerv Syst2005. 21:477\u2013481."},{"key":"i1543-2165-133-7-1062-b3","series-title":"Neuro Oncol","first-page":"188","article-title":"Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.","volume":"5","author":"Hukin, J.","year":"2003","unstructured":"Hukin, J., J.Siffert, H.Cohen, L.Velasquez, D.Zagzag, and J.Allen. Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors.Neuro Oncol2003. 5:188\u2013196."},{"key":"i1543-2165-133-7-1062-b4","series-title":"J Clin Neurosci","first-page":"725","article-title":"Spinal leptomeningeal metastases following glioblastoma multiforme treated with radiotherapy.","volume":"9","author":"Lindsay, A.","year":"2002","unstructured":"Lindsay, A., D.Holthouse, P.Robbins, and N.Knuckey. Spinal leptomeningeal metastases following glioblastoma multiforme treated with radiotherapy.J Clin Neurosci2002. 9:725\u2013728."},{"key":"i1543-2165-133-7-1062-b5","series-title":"J Neurooncol","first-page":"227","article-title":"Symptomatic spinal dissemination of malignant astrocytoma.","volume":"61","author":"Saito, R.","year":"2003","unstructured":"Saito, R., T.Kumabe, H.Jokura, R.Shirane, and T.Yoshimoto. Symptomatic spinal dissemination of malignant astrocytoma.J Neurooncol2003. 61:227\u2013235."},{"key":"i1543-2165-133-7-1062-b6","series-title":"Br J Cancer","first-page":"991","article-title":"Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.","volume":"95","author":"Wagner, S.","year":"2006","unstructured":"Wagner, S., M.Benesch, and F.Berthold. et al. Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.Br J Cancer2006. 95:991\u2013997."},{"key":"i1543-2165-133-7-1062-b7","series-title":"Brain Pathol","first-page":"319","article-title":"Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma.","volume":"17","author":"Brat, D. J.","year":"2007","unstructured":"Brat, D. J., B. W.Scheithauer, G. N.Fuller, and T.Tihan. Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: angiocentric glioma, pilomyxoid astrocytoma and pituicytoma.Brain Pathol2007. 17:319\u2013324."},{"key":"i1543-2165-133-7-1062-b8","series-title":"Brain Pathol","first-page":"304","article-title":"The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.","volume":"17","author":"Fuller, G. N.","year":"2007","unstructured":"Fuller, G. N. and B. W.Scheithauer. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.Brain Pathol2007. 17:304\u2013307."},{"key":"i1543-2165-133-7-1062-b9","series-title":"Acta Neuropathol","first-page":"97","article-title":"The 2007 WHO classification of tumours of the central nervous system.","volume":"114","author":"Louis, D. N.","year":"2007","unstructured":"Louis, D. N., H.Ohgaki, and O. D.Wiestler. et al. The 2007 WHO classification of tumours of the central nervous system.Acta Neuropathol2007. 114:97\u2013109."},{"key":"i1543-2165-133-7-1062-b10","series-title":"Brain Pathol","first-page":"314","article-title":"Papillary tumor of the pineal region and spindle cell oncocytoma of the pituitary: new tumor entities in the 2007 WHO Classification.","volume":"17","author":"Roncaroli, F.","year":"2007","unstructured":"Roncaroli, F. and B. W.Scheithauer. Papillary tumor of the pineal region and spindle cell oncocytoma of the pituitary: new tumor entities in the 2007 WHO Classification.Brain Pathol2007. 17:314\u2013318."},{"key":"i1543-2165-133-7-1062-b11","series-title":"Brain Pathol","first-page":"308","article-title":"The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group.","volume":"17","author":"Rosenblum, M. K.","year":"2007","unstructured":"Rosenblum, M. K.\n          \n          The 2007 WHO Classification of Nervous System Tumors: newly recognized members of the mixed glioneuronal group.\n          Brain Pathol\n          2007. 17:308\u2013313."},{"key":"i1543-2165-133-7-1062-b12","series-title":"Arch Pathol Lab Med","first-page":"993","article-title":"Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.","volume":"132","author":"Brat, D. J.","year":"2008","unstructured":"Brat, D. J., J. E.Parisi, and B. K.Kleinschmidt-Demasters. et al. Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.Arch Pathol Lab Med2008. 132:993\u20131007."},{"key":"i1543-2165-133-7-1062-b13","series-title":"Onkologie","first-page":"192","article-title":"Extraneural spread of glioblastoma\u2014 report of two cases.","volume":"31","author":"Templeton, A.","year":"2008","unstructured":"Templeton, A., S.Hofer, and M.Topfer. et al. Extraneural spread of glioblastoma\u2014 report of two cases.Onkologie2008. 31:192\u2013194."},{"key":"i1543-2165-133-7-1062-b14","series-title":"Transplantation","first-page":"340","article-title":"Donors with central nervous system malignancies: are they truly safe?","volume":"76","author":"Buell, J. F.","year":"2003","unstructured":"Buell, J. F., J.Trofe, and G.Sethuraman. et al. Donors with central nervous system malignancies: are they truly safe?Transplantation2003. 76:340\u2013343."},{"key":"i1543-2165-133-7-1062-b15","series-title":"N Engl J Med","first-page":"987","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.","volume":"352","author":"Stupp, R.","year":"2005","unstructured":"Stupp, R., W. P.Mason, and M. J.van den Bent. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med2005. 352:987\u2013996."},{"key":"i1543-2165-133-7-1062-b16","series-title":"Neuro Oncol","first-page":"189","article-title":"A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.","volume":"8","author":"Prados, M. D.","year":"2006","unstructured":"Prados, M. D., K.Lamborn, and W. K.Yung. et al. A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.Neuro Oncol2006. 8:189\u2013193."},{"key":"i1543-2165-133-7-1062-b17","series-title":"Neuro Oncol","first-page":"216","article-title":"Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.","volume":"10","author":"Puduvalli, V. K.","year":"2008","unstructured":"Puduvalli, V. K., P.Giglio, and M. D.Groves. et al. Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.Neuro Oncol2008. 10:216\u2013222."},{"key":"i1543-2165-133-7-1062-b18","series-title":"J Clin Oncol","first-page":"4722","article-title":"Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.","volume":"25","author":"Vredenburgh, J. J.","year":"2007","unstructured":"Vredenburgh, J. J., A.Desjardins, and J. E2ndHerndon. et al. Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.J Clin Oncol2007. 25:4722\u20134729."},{"key":"i1543-2165-133-7-1062-b19","series-title":"Neurology","first-page":"779","article-title":"Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.","volume":"70","author":"Norden, A. D.","year":"2008","unstructured":"Norden, A. D., G. S.Young, and K.Setayesh. et al. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.Neurology2008. 70:779\u2013787."},{"key":"i1543-2165-133-7-1062-b20","series-title":"Clin Cancer Res","first-page":"1931","article-title":"Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.","volume":"2","author":"Yung, W. K.","year":"1996","unstructured":"Yung, W. K., A. P.Kyritsis, M. J.Gleason, and V. A.Levin. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.Clin Cancer Res1996. 2:1931\u20131935."},{"key":"i1543-2165-133-7-1062-b21","series-title":"Neuro Oncol","first-page":"44","article-title":"Primary and secondary glioblastomas: from concept to clinical diagnosis.","volume":"1","author":"Kleihues, P.","year":"1999","unstructured":"Kleihues, P. and H.Ohgaki. Primary and secondary glioblastomas: from concept to clinical diagnosis.Neuro Oncol1999. 1:44\u201351."},{"key":"i1543-2165-133-7-1062-b22","series-title":"Cancer Res","first-page":"159","article-title":"Distinct transcription profiles of primary and secondary glioblastoma subgroups.","volume":"66","author":"Tso, C. L.","year":"2006","unstructured":"Tso, C. L., W. A.Freije, and A.Day. et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups.Cancer Res2006. 66:159\u2013167."},{"key":"i1543-2165-133-7-1062-b23","series-title":"Cancer Biol Ther","first-page":"242","article-title":"Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.","volume":"2","author":"Mischel, P. S.","year":"2003","unstructured":"Mischel, P. S., S. F.Nelson, and T. F.Cloughesy. Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.Cancer Biol Ther2003. 2:242\u2013247."},{"key":"i1543-2165-133-7-1062-b24","series-title":"Mol Cancer Res","first-page":"607","article-title":"Primary glioblastomas express mesenchymal stem-like properties.","volume":"4","author":"Tso, C. L.","year":"2006","unstructured":"Tso, C. L., P.Shintaku, and J.Chen. et al. Primary glioblastomas express mesenchymal stem-like properties.Mol Cancer Res2006. 4:607\u2013619."},{"key":"i1543-2165-133-7-1062-b25","series-title":"Cancer Res","first-page":"11502","article-title":"Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.","volume":"66","author":"Maher, E. A.","year":"2006","unstructured":"Maher, E. A., C.Brennan, and P. Y.Wen. et al. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.Cancer Res2006. 66:11502\u201311513."},{"key":"i1543-2165-133-7-1062-b26","series-title":"Cancer Cell","first-page":"157","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.","volume":"9","author":"Phillips, H. S.","year":"2006","unstructured":"Phillips, H. S., S.Kharbanda, and R.Chen. et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.Cancer Cell2006. 9:157\u2013173."},{"key":"i1543-2165-133-7-1062-b27","series-title":"Am J Pathol","first-page":"425","article-title":"Genetic profile of gliosarcomas.","volume":"156","author":"Reis, R. M.","year":"2000","unstructured":"Reis, R. M., D.Konu-Lebleblicioglu, J. M.Lopes, P.Kleihues, and H.Ohgaki. Genetic profile of gliosarcomas.Am J Pathol2000. 156:425\u2013432."},{"key":"i1543-2165-133-7-1062-b28","series-title":"Lab Invest","first-page":"123","article-title":"Genetic profile of the giant cell glioblastoma.","volume":"79","author":"Peraud, A.","year":"1999","unstructured":"Peraud, A., K.Watanabe, K.Schwechheimer, Y.Yonekawa, P.Kleihues, and H.Ohgaki. Genetic profile of the giant cell glioblastoma.Lab Invest1999. 79:123\u2013129."},{"key":"i1543-2165-133-7-1062-b29","series-title":"Genes Chromosomes Cancer","first-page":"416","article-title":"Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.","volume":"34","author":"Actor, B.","year":"2002","unstructured":"Actor, B., J. M.Cobbers, and R.Buschges. et al. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.Genes Chromosomes Cancer2002. 34:416\u2013427."},{"key":"i1543-2165-133-7-1062-b30","series-title":"J Neuropathol Exp Neurol","first-page":"1","article-title":"Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.","volume":"67","author":"Yip, S.","year":"2008","unstructured":"Yip, S., A. J.Iafrate, and D. N.Louis. Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers.J Neuropathol Exp Neurol2008. 67:1\u201315."},{"key":"i1543-2165-133-7-1062-b31","series-title":"Clin Cancer Res","first-page":"378","article-title":"PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors.","volume":"13","author":"Mellinghoff, I. K.","year":"2007","unstructured":"Mellinghoff, I. K., T. F.Cloughesy, and P. S.Mischel. PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors.Clin Cancer Res2007. 13:378\u2013381."},{"key":"i1543-2165-133-7-1062-b32","series-title":"N Engl J Med","first-page":"2012","article-title":"Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.","volume":"353","author":"Mellinghoff, I. K.","year":"2005","unstructured":"Mellinghoff, I. K., M. Y.Wang, and I.Vivanco. et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.N Engl J Med2005. 353:2012\u20132024."},{"key":"i1543-2165-133-7-1062-b33","series-title":"Nat Rev Cancer","first-page":"489","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer.","volume":"2","author":"Vivanco, I.","year":"2002","unstructured":"Vivanco, I. and C. L.Sawyers. The phosphatidylinositol 3-Kinase AKT pathway in human cancer.Nat Rev Cancer2002. 2:489\u2013501."},{"key":"i1543-2165-133-7-1062-b34","series-title":"Clin Cancer Res","first-page":"7841","article-title":"Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.","volume":"11","author":"Lassman, A. B.","year":"2005","unstructured":"Lassman, A. B., M. R.Rossi, and J. J.Raizer. et al. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.Clin Cancer Res2005. 11:7841\u20137850."},{"issue":"2","key":"i1543-2165-133-7-1062-b35","series-title":"J Neurooncol","first-page":"211","article-title":"Epithelial Growth Factor Receptor inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.","volume":"89","author":"Preusser, M.","year":"2008","unstructured":"Preusser, M., E.Gelpi, and A.Rottenfusser. et al. Epithelial Growth Factor Receptor inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.J Neurooncol2008. 892:211\u2013218."},{"key":"i1543-2165-133-7-1062-b36","series-title":"J Natl Cancer Inst","first-page":"880","article-title":"Epidermal growth factor receptor, protein kinase B\/Akt, and glioma response to erlotinib.","volume":"97","author":"Haas-Kogan, D. A.","year":"2005","unstructured":"Haas-Kogan, D. A., M. D.Prados, and T.Tihan. et al. Epidermal growth factor receptor, protein kinase B\/Akt, and glioma response to erlotinib.J Natl Cancer Inst2005. 97:880\u2013887."},{"key":"i1543-2165-133-7-1062-b37","series-title":"Cancer Res","first-page":"7864","article-title":"Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.","volume":"66","author":"Wang, M. Y.","year":"2006","unstructured":"Wang, M. Y., K. V.Lu, and S.Zhu. et al. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells.Cancer Res2006. 66:7864\u20137869."},{"key":"i1543-2165-133-7-1062-b38","series-title":"Expert Opin Ther Targets","first-page":"349","article-title":"S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.","volume":"11","author":"Juillerat, A.","year":"2007","unstructured":"Juillerat, A. and L.Juillerat-Jeanneret. S-alkylthiolation of O6-methylguanine-DNA-methyltransferase (MGMT) to sensitize cancer cells to anticancer therapy.Expert Opin Ther Targets2007. 11:349\u2013361."},{"key":"i1543-2165-133-7-1062-b39","series-title":"N Engl J Med","first-page":"997","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma.","volume":"352","author":"Hegi, M. E.","year":"2005","unstructured":"Hegi, M. E., A. C.Diserens, and T.Gorlia. et al. MGMT gene silencing and benefit from temozolomide in glioblastoma.N Engl J Med2005. 352:997\u20131003."},{"key":"i1543-2165-133-7-1062-b40","article-title":"Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.","author":"Preusser, M.","unstructured":"Preusser, M., R. C.Janzer, and J.Felsberg. et al. Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.Brain Pathol. 2008;18(4):520\u2013532."},{"key":"i1543-2165-133-7-1062-b41","series-title":"Neurology","first-page":"535","article-title":"Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.","volume":"63","author":"de Wit, M. C.","year":"2004","unstructured":"de Wit, M. C., H. G.de Bruin, W.Eijkenboom, P. A.Sillevis Smitt, and M. J.van den Bent. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.Neurology2004. 63:535\u2013537."},{"key":"i1543-2165-133-7-1062-b42","series-title":"Lancet Oncol","first-page":"453","article-title":"Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.","volume":"9","author":"Brandsma, D.","year":"2008","unstructured":"Brandsma, D., L.Stalpers, W.Taal, P.Sminia, and M. J.van den Bent. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.Lancet Oncol2008. 9:453\u2013461."},{"issue":"2","key":"i1543-2165-133-7-1062-b43","series-title":"Cancer","first-page":"405","article-title":"Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.","volume":"113","author":"Taal, W.","year":"2008","unstructured":"Taal, W., D.Brandsma, and H. G.de Bruin. et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide.Cancer2008. 1132:405\u2013410."},{"key":"i1543-2165-133-7-1062-b44","series-title":"J Neurooncol","first-page":"81","article-title":"Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.","volume":"82","author":"Chamberlain, M. C.","year":"2007","unstructured":"Chamberlain, M. C., M. J.Glantz, L.Chalmers, A.Van Horn, and A. E.Sloan. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma.J Neurooncol2007. 82:81\u201383."},{"key":"i1543-2165-133-7-1062-b45","series-title":"Surg Neurol","first-page":"649","article-title":"The effect of bevacizumab (Avastin) on neuroimaging of brain metastases.","volume":"70(6)","author":"Mathews, M. S.","year":"2008","unstructured":"Mathews, M. S., M. E.Linskey, A. N.Hasso, and J. P.Fruehauf. The effect of bevacizumab (Avastin) on neuroimaging of brain metastases.Surg Neurol2008. 70(6):649\u2013652."},{"key":"i1543-2165-133-7-1062-b46","series-title":"J Neurooncol","first-page":"339","article-title":"Time course of imaging changes of GBM during extended bevacizumab treatment.","volume":"88","author":"Ananthnarayan, S.","year":"2008","unstructured":"Ananthnarayan, S., J.Bahng, and J.Roring. et al. Time course of imaging changes of GBM during extended bevacizumab treatment.J Neurooncol2008. 88:339\u2013347."},{"key":"i1543-2165-133-7-1062-b47","series-title":"Science","first-page":"983","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.","volume":"219","author":"Senger, D. R.","year":"1983","unstructured":"Senger, D. R., S. J.Galli, A. M.Dvorak, C. A.Perruzzi, V. S.Harvey, and H. F.Dvorak. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.Science1983. 219:983\u2013985."},{"key":"i1543-2165-133-7-1062-b48","series-title":"Int J Radiat Oncol Biol Phys","first-page":"323","article-title":"Effect of bevacizumab on radiation necrosis of the brain.","volume":"67","author":"Gonzalez, J.","year":"2007","unstructured":"Gonzalez, J., A. J.Kumar, C. A.Conrad, and V. A.Levin. Effect of bevacizumab on radiation necrosis of the brain.Int J Radiat Oncol Biol Phys2007. 67:323\u2013326."},{"key":"i1543-2165-133-7-1062-b49","series-title":"Oncologist","first-page":"165","article-title":"Changing paradigms\u2014an update on the multidisciplinary management of malignant glioma.","volume":"11","author":"Stupp, R.","year":"2006","unstructured":"Stupp, R., M. E.Hegi, and M. J.van den Bent. et al. Changing paradigms\u2014an update on the multidisciplinary management of malignant glioma.Oncologist2006. 11:165\u2013180."},{"key":"i1543-2165-133-7-1062-b50","series-title":"Histopathology","first-page":"437","article-title":"Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.","volume":"37","author":"Cheng, Y.","year":"2000","unstructured":"Cheng, Y., J. C.Pang, and H. K.Ng. et al. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.Histopathology2000. 37:437\u2013444."},{"key":"i1543-2165-133-7-1062-b51","series-title":"Cancer Res","first-page":"6885","article-title":"Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.","volume":"61","author":"Rickman, D. S.","year":"2001","unstructured":"Rickman, D. S., M. P.Bobek, and D. E.Misek. et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis.Cancer Res2001. 61:6885\u20136891."},{"key":"i1543-2165-133-7-1062-b52","series-title":"J Neuropathol Exp Neurol","first-page":"769","article-title":"Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.","volume":"65","author":"Addo-Yobo, S. O.","year":"2006","unstructured":"Addo-Yobo, S. O., J.Straessle, A.Anwar, A. M.Donson, B. K.Kleinschmidt-Demasters, and N. K.Foreman. Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.J Neuropathol Exp Neurol2006. 65:769\u2013775."},{"key":"i1543-2165-133-7-1062-b53","series-title":"Cancer","first-page":"1569","article-title":"A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.","volume":"89","author":"Fisher, P. G.","year":"2000","unstructured":"Fisher, P. G., S. N.Breiter, and B. S.Carson. et al. A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities.Cancer2000. 89:1569\u20131576."},{"key":"i1543-2165-133-7-1062-b54","series-title":"Neuro Oncol","first-page":"168","article-title":"Pathology of low-grade gliomas: an update of emerging concepts.","volume":"5","author":"Perry, A.","year":"2003","unstructured":"Perry, A.\n          \n          Pathology of low-grade gliomas: an update of emerging concepts.\n          Neuro Oncol\n          2003. 5:168\u2013178."},{"key":"i1543-2165-133-7-1062-b55","series-title":"Spinal Cord","first-page":"282","article-title":"Surgical treatment of intramedullary spinal cord tumors: prognosis and complications.","volume":"46","author":"Nakamura, M.","year":"2008","unstructured":"Nakamura, M., K.Ishii, and K.Watanabe. et al. Surgical treatment of intramedullary spinal cord tumors: prognosis and complications.Spinal Cord2008. 46:282\u2013286."},{"key":"i1543-2165-133-7-1062-b56","series-title":"J Clin Neurosci","first-page":"20","article-title":"Spinal cord gliomas: management and outcome with reference to adjuvant therapy.","volume":"7","author":"Nishio, S.","year":"2000","unstructured":"Nishio, S., T.Morioka, K.Fujii, T.Inamura, and M.Fukui. Spinal cord gliomas: management and outcome with reference to adjuvant therapy.J Clin Neurosci2000. 7:20\u201323."},{"key":"i1543-2165-133-7-1062-b57","series-title":"J Pathol Bacteriol","first-page":"735","article-title":"Oligodendrogliomas of the brain.","volume":"32","author":"Bailey, P.","year":"1929","unstructured":"Bailey, P. and P. C.Bucy. Oligodendrogliomas of the brain.J Pathol Bacteriol1929. 32:735\u2013751."},{"key":"i1543-2165-133-7-1062-b58","series-title":"Nature","first-page":"396","article-title":"Identification of human brain tumour initiating cells.","volume":"432","author":"Singh, S. K.","year":"2004","unstructured":"Singh, S. K., C.Hawkins, and I. D.Clarke. et al. Identification of human brain tumour initiating cells.Nature2004. 432:396\u2013401."},{"key":"i1543-2165-133-7-1062-b59","series-title":"J Neuropathol Exp Neurol","first-page":"947","article-title":"Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.","volume":"61","author":"Perry, A.","year":"2002","unstructured":"Perry, A., B. W.Scheithauer, R. J.Macaulay, C.Raffel, K. A.Roth, and J. M.Kros. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.J Neuropathol Exp Neurol2002. 61:947\u2013955."},{"key":"i1543-2165-133-7-1062-b60","series-title":"Arch Pathol Lab Med","first-page":"1532","article-title":"Frozen section discrepancy in the evaluation of central nervous system tumors.","volume":"131","author":"Plesec, T. P.","year":"2007","unstructured":"Plesec, T. P. and R. A.Prayson. Frozen section discrepancy in the evaluation of central nervous system tumors.Arch Pathol Lab Med2007. 131:1532\u20131540."},{"key":"i1543-2165-133-7-1062-b61","series-title":"Semin Diagn Pathol","first-page":"251","article-title":"Oligodendroglioma: diagnosis and prognosis.","volume":"4","author":"Bruner, J. M.","year":"1987","unstructured":"Bruner, J. M.\n          \n          Oligodendroglioma: diagnosis and prognosis.\n          Semin Diagn Pathol\n          1987. 4:251\u2013261."},{"key":"i1543-2165-133-7-1062-b62","series-title":"Neurosurgery","first-page":"1279","article-title":"Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.","volume":"45","author":"Fortin, D.","year":"1999","unstructured":"Fortin, D., G. J.Cairncross, and R. R.Hammond. Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.Neurosurgery1999. 45:1279\u20131291."},{"key":"i1543-2165-133-7-1062-b63","series-title":"Cancer","first-page":"1381","article-title":"Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas.","volume":"79","author":"Coons, S. W.","year":"1997","unstructured":"Coons, S. W., P. C.Johnson, B. W.Scheithauer, A. J.Yates, and D. K.Pearl. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas.Cancer1997. 79:1381\u20131393."},{"key":"i1543-2165-133-7-1062-b64","series-title":"Adv Anat Pathol","first-page":"183","article-title":"Oligodendroglial neoplasms: current concepts, misconceptions, and folklore.","volume":"8","author":"Perry, A.","year":"2001","unstructured":"Perry, A.\n          \n          Oligodendroglial neoplasms: current concepts, misconceptions, and folklore.\n          Adv Anat Pathol\n          2001. 8:183\u2013199."},{"key":"i1543-2165-133-7-1062-b65","series-title":"Neurosurgery","first-page":"878","article-title":"The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.","volume":"41","author":"Coons, S. W.","year":"1997","unstructured":"Coons, S. W., P. C.Johnson, and D. K.Pearl. The prognostic significance of Ki-67 labeling indices for oligodendrogliomas.Neurosurgery1997. 41:878\u2013884."},{"key":"i1543-2165-133-7-1062-b66","series-title":"Cancer","first-page":"1107","article-title":"Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.","volume":"78","author":"Kros, J. M.","year":"1996","unstructured":"Kros, J. M., W. C.Hop, J. J.Godschalk, and K. K.Krishnadath. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.Cancer1996. 78:1107\u20131113."},{"key":"i1543-2165-133-7-1062-b67","series-title":"Cancer","first-page":"1345","article-title":"Clinicopathologic correlations in the oligodendroglioma.","volume":"59","author":"Burger, P. C.","year":"1987","unstructured":"Burger, P. C., C. E.Rawlings, E. B.Cox, R. E.McLendon, S. C. JrSchold, and D. E.Bullard. Clinicopathologic correlations in the oligodendroglioma.Cancer1987. 59:1345\u20131352."},{"key":"i1543-2165-133-7-1062-b68","series-title":"Cancer","first-page":"2107","article-title":"Grading of oligodendrogliomas.","volume":"52","author":"Smith, M. T.","year":"1983","unstructured":"Smith, M. T., C. L.Ludwig, A. D.Godfrey, and V. W.Armbrustmacher. Grading of oligodendrogliomas.Cancer1983. 52:2107\u20132114."},{"key":"i1543-2165-133-7-1062-b69","series-title":"J Neuropathol Exp Neurol","first-page":"65","article-title":"Oligodendroglioma. Histologic evaluation and prognosis.","volume":"45","author":"Mork, S. J.","year":"1986","unstructured":"Mork, S. J., T. B.Halvorsen, K. F.Lindegaard, and G. E.Eide. Oligodendroglioma. Histologic evaluation and prognosis.J Neuropathol Exp Neurol1986. 45:65\u201378."},{"key":"i1543-2165-133-7-1062-b70","series-title":"J Clin Oncol","first-page":"5419","article-title":"Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.","volume":"24","author":"Miller, C. R.","year":"2006","unstructured":"Miller, C. R., C. P.Dunham, B. W.Scheithauer, and A.Perry. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.J Clin Oncol2006. 24:5419\u20135426."},{"key":"i1543-2165-133-7-1062-b71","series-title":"Brain Pathol","first-page":"360","article-title":"Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.","volume":"18","author":"Giannini, C.","year":"2008","unstructured":"Giannini, C., P. C.Burger, and B. A.Berkey. et al. Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.Brain Pathol2008. 18:360\u2013369."},{"key":"i1543-2165-133-7-1062-b72","series-title":"J Neuropathol Exp Neurol","first-page":"545","article-title":"Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p\/19q loss, and correlations with outcome.","volume":"66","author":"Kros, J. M.","year":"2007","unstructured":"Kros, J. M., T.Gorlia, and M. C.Kouwenhoven. et al. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p\/19q loss, and correlations with outcome.J Neuropathol Exp Neurol2007. 66:545\u2013551."},{"key":"i1543-2165-133-7-1062-b73","series-title":"J Neuropathol Exp Neurol","first-page":"988","article-title":"Identification of der(1;19)(q10; p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.","volume":"65","author":"Griffin, C. A.","year":"2006","unstructured":"Griffin, C. A., P.Burger, and L.Morsberger. et al. Identification of der(1;19)(q10; p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss.J Neuropathol Exp Neurol2006. 65:988\u2013994."},{"key":"i1543-2165-133-7-1062-b74","series-title":"Cancer Res","first-page":"9852","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.","volume":"66","author":"Jenkins, R. B.","year":"2006","unstructured":"Jenkins, R. B., H.Blair, and K. V.Ballman. et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma.Cancer Res2006. 66:9852\u20139861."},{"key":"i1543-2165-133-7-1062-b75","series-title":"Clin Cancer Res","first-page":"1119","article-title":"Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.","volume":"11","author":"Barbashina, V.","year":"2005","unstructured":"Barbashina, V., P.Salazar, E. C.Holland, M. K.Rosenblum, and M.Ladanyi. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res2005. 11:1119\u20131128."},{"key":"i1543-2165-133-7-1062-b76","series-title":"Brain Pathol","first-page":"121","article-title":"Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p\/19q status with survival.","volume":"14","author":"Felsberg, J.","year":"2004","unstructured":"Felsberg, J., A.Erkwoh, and M. C.Sabel. et al. Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p\/19q status with survival.Brain Pathol2004. 14:121\u2013130."},{"key":"i1543-2165-133-7-1062-b77","series-title":"Int J Cancer","first-page":"792","article-title":"Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.","volume":"119","author":"Tews, B.","year":"2006","unstructured":"Tews, B., J.Felsberg, and C.Hartmann. et al. Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling.Int J Cancer2006. 119:792\u2013800."},{"key":"i1543-2165-133-7-1062-b78","series-title":"J Natl Cancer Inst","first-page":"1473","article-title":"Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.","volume":"90","author":"Cairncross, J. G.","year":"1998","unstructured":"Cairncross, J. G., K.Ueki, and M. C.Zlatescu. et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.J Natl Cancer Inst1998. 90:1473\u20131479."},{"key":"i1543-2165-133-7-1062-b79","series-title":"Cancer","first-page":"1276","article-title":"Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.","volume":"97","author":"van den Bent, M. J.","year":"2003","unstructured":"van den Bent, M. J., L. H.Looijenga, and K.Langenberg. et al. Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.Cancer2003. 97:1276\u20131284."},{"key":"i1543-2165-133-7-1062-b80","series-title":"Arch Pathol Lab Med","first-page":"242","article-title":"Clinicopathologic aspects of 1p\/19q loss and the diagnosis of oligodendroglioma.","volume":"131","author":"Aldape, K.","year":"2007","unstructured":"Aldape, K., P. C.Burger, and A.Perry. Clinicopathologic aspects of 1p\/19q loss and the diagnosis of oligodendroglioma.Arch Pathol Lab Med2007. 131:242\u2013251."},{"key":"i1543-2165-133-7-1062-b81","series-title":"J Clin Oncol","first-page":"636","article-title":"Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.","volume":"18","author":"Smith, J. S.","year":"2000","unstructured":"Smith, J. S., A.Perry, and T. J.Borell. et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.J Clin Oncol2000. 18:636\u2013645."},{"key":"i1543-2165-133-7-1062-b82","series-title":"J Neurooncol","first-page":"293","article-title":"Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.","volume":"88","author":"Iwamoto, F. M.","year":"2008","unstructured":"Iwamoto, F. M., L.Nicolardi, and A.Demopoulos. et al. Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.J Neurooncol2008. 88:293\u2013298."},{"key":"i1543-2165-133-7-1062-b83","series-title":"J Clin Oncol","first-page":"2707","article-title":"Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.","volume":"24","author":"Cairncross, G.","year":"2006","unstructured":"Cairncross, G., B.Berkey, and E.Shaw. et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.J Clin Oncol2006. 24:2707\u20132714."},{"key":"i1543-2165-133-7-1062-b84","series-title":"J Clin Oncol","first-page":"2715","article-title":"Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.","volume":"24","author":"van den Bent, M. J.","year":"2006","unstructured":"van den Bent, M. J., A. F.Carpentier, and A. A.Brandes. et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial.J Clin Oncol2006. 24:2715\u20132722."},{"key":"i1543-2165-133-7-1062-b85","series-title":"Can J Neurol Sci","first-page":"215","article-title":"PCV for oligodendroglial tumors: in search of prognostic factors for response and survival.","volume":"28","author":"Fortin, D.","year":"2001","unstructured":"Fortin, D., D. R.Macdonald, L.Stitt, and J. G.Cairncross. PCV for oligodendroglial tumors: in search of prognostic factors for response and survival.Can J Neurol Sci2001. 28:215\u2013223."},{"key":"i1543-2165-133-7-1062-b86","series-title":"J Neurooncol","first-page":"267","article-title":"Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.","volume":"61","author":"Chahlavi, A.","year":"2003","unstructured":"Chahlavi, A., A.Kanner, D.Peereboom, S. M.Staugaitis, P.Elson, and G.Barnett. Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results.J Neurooncol2003. 61:267\u2013273."},{"key":"i1543-2165-133-7-1062-b87","series-title":"Eur J Cancer","first-page":"2499","article-title":"1p\/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.","volume":"42","author":"Kouwenhoven, M. C.","year":"2006","unstructured":"Kouwenhoven, M. C., J. M.Kros, and P. J.French. et al. 1p\/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.Eur J Cancer2006. 42:2499\u20132503."},{"key":"i1543-2165-133-7-1062-b88","series-title":"Neurology","first-page":"1831","article-title":"Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome.","volume":"68","author":"Kaloshi, G.","year":"2007","unstructured":"Kaloshi, G., A.Benouaich-Amiel, and F.Diakite. et al. Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome.Neurology2007. 68:1831\u20131836."},{"key":"i1543-2165-133-7-1062-b89","series-title":"Ann Oncol","first-page":"942","article-title":"Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide.","volume":"16","author":"Brada, M.","year":"2005","unstructured":"Brada, M., S.Ashley, and A.Dowe. et al. Neoadjuvant phase II multicentre study of new agents in patients with malignant glioma after minimal surgery. Report of a cohort of 187 patients treated with temozolomide.Ann Oncol2005. 16:942\u2013949."},{"key":"i1543-2165-133-7-1062-b90","series-title":"Clin Cancer Res","first-page":"6933","article-title":"Combined 1p\/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?","volume":"13","author":"Weller, M.","year":"2007","unstructured":"Weller, M., H.Berger, and C.Hartmann. et al. Combined 1p\/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?Clin Cancer Res2007. 13:6933\u20136937."},{"key":"i1543-2165-133-7-1062-b91","series-title":"Neurosurgery","first-page":"545","article-title":"Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.","volume":"23","author":"Daumas-Duport, C.","year":"1988","unstructured":"Daumas-Duport, C., B. W.Scheithauer, J. P.Chodkiewicz, E. R. JrLaws, and C.Vedrenne. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.Neurosurgery1988. 23:545\u2013556."},{"key":"i1543-2165-133-7-1062-b92","series-title":"Cancer","first-page":"989","article-title":"Ganglioglioma: an ultrastructural and immunohistochemical study.","volume":"79","author":"Hirose, T.","year":"1997","unstructured":"Hirose, T., B. W.Scheithauer, M. B.Lopes, H. A.Gerber, H. J.Altermatt, and S. R.VandenBerg. Ganglioglioma: an ultrastructural and immunohistochemical study.Cancer1997. 79:989\u20131003."},{"key":"i1543-2165-133-7-1062-b93","series-title":"Acta Neuropathol","first-page":"166","article-title":"Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases.","volume":"88","author":"Wolf, H. K.","year":"1994","unstructured":"Wolf, H. K., M. B.Muller, M.Spanle, J.Zentner, J.Schramm, and O. D.Wiestler. Ganglioglioma: a detailed histopathological and immunohistochemical analysis of 61 cases.Acta Neuropathol1994. 88:166\u2013173."},{"key":"i1543-2165-133-7-1062-b94","series-title":"J Neurosurg","first-page":"58","article-title":"Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential (\u201cdesmoplastic infantile gangliogliomas\u201d). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis.","volume":"66","author":"VandenBerg, S. R.","year":"1987","unstructured":"VandenBerg, S. R., E. E.May, and L. J.Rubinstein. et al. Desmoplastic supratentorial neuroepithelial tumors of infancy with divergent differentiation potential (\u201cdesmoplastic infantile gangliogliomas\u201d). Report on 11 cases of a distinctive embryonal tumor with favorable prognosis.J Neurosurg1987. 66:58\u201371."},{"key":"i1543-2165-133-7-1062-b95","series-title":"Arch Pathol Lab Med","first-page":"228","article-title":"Mixed glioneuronal tumors: recently described entities.","volume":"131","author":"Edgar, M. A.","year":"2007","unstructured":"Edgar, M. A. and M. K.Rosenblum. Mixed glioneuronal tumors: recently described entities.Arch Pathol Lab Med2007. 131:228\u2013233."},{"key":"i1543-2165-133-7-1062-b96","series-title":"Am J Surg Pathol","first-page":"582","article-title":"A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor?","volume":"26","author":"Komori, T.","year":"2002","unstructured":"Komori, T., B. W.Scheithauer, and T.Hirose. A rosette-forming glioneuronal tumor of the fourth ventricle: infratentorial form of dysembryoplastic neuroepithelial tumor?Am J Surg Pathol2002. 26:582\u2013591."},{"key":"i1543-2165-133-7-1062-b97","series-title":"Am J Surg Pathol","first-page":"1171","article-title":"Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm.","volume":"22","author":"Komori, T.","year":"1998","unstructured":"Komori, T., B. W.Scheithauer, and D. C.Anthony. et al. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm.Am J Surg Pathol1998. 22:1171\u20131183."},{"key":"i1543-2165-133-7-1062-b98","series-title":"Am J Surg Pathol","first-page":"502","article-title":"A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including \u201crosetted\u201d) islands: report of 4 cases.","volume":"23","author":"Teo, J. G.","year":"1999","unstructured":"Teo, J. G., S. H.Gultekin, M.Bilsky, P.Gutin, and M. K.Rosenblum. A distinctive glioneuronal tumor of the adult cerebrum with neuropil-like (including \u201crosetted\u201d) islands: report of 4 cases.Am J Surg Pathol1999. 23:502\u2013510."},{"key":"i1543-2165-133-7-1062-b99","series-title":"Am J Surg Pathol","first-page":"1196","article-title":"Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p\/19q deletion analysis.","volume":"31","author":"Barbashina, V.","year":"2007","unstructured":"Barbashina, V., P.Salazar, M.Ladanyi, M. K.Rosenblum, and M. A.Edgar. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p\/19q deletion analysis.Am J Surg Pathol2007. 31:1196\u20131202."},{"key":"i1543-2165-133-7-1062-b100","series-title":"J Neurosurg","first-page":"1055","article-title":"Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. Case report.","volume":"84","author":"Sasaki, A.","year":"1996","unstructured":"Sasaki, A., J.Hirato, Y.Nakazato, M.Tamura, and H.Kadowaki. Recurrent anaplastic ganglioglioma: pathological characterization of tumor cells. Case report.J Neurosurg1996. 84:1055\u20131059."},{"key":"i1543-2165-133-7-1062-b101","series-title":"Pediatr Neurosurg","first-page":"132","article-title":"Malignant glial tumor arising from the site of a previous hamartoma\/ganglioglioma: coincidence or malignant transformation?","volume":"30","author":"Mittler, M. A.","year":"1999","unstructured":"Mittler, M. A., B. C.Walters, A. H.Fried, E. A.Sotomayor, and E. G.Stopa. Malignant glial tumor arising from the site of a previous hamartoma\/ganglioglioma: coincidence or malignant transformation?Pediatr Neurosurg1999. 30:132\u2013134."},{"key":"i1543-2165-133-7-1062-b102","series-title":"Pediatr Neurosurg","first-page":"301","article-title":"Oligodendroglial ganglioglioma with anaplastic features arising from the thalamus.","volume":"34","author":"Johnson, M. D.","year":"2001","unstructured":"Johnson, M. D., M. T.Jennings, and S. T.Toms. Oligodendroglial ganglioglioma with anaplastic features arising from the thalamus.Pediatr Neurosurg2001. 34:301\u2013305."},{"key":"i1543-2165-133-7-1062-b103","series-title":"Cancer","first-page":"146","article-title":"Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.","volume":"101","author":"Luyken, C.","year":"2004","unstructured":"Luyken, C., I.Blumcke, R.Fimmers, H.Urbach, O. D.Wiestler, and J.Schramm. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years.Cancer2004. 101:146\u2013155."},{"key":"i1543-2165-133-7-1062-b104","series-title":"Ann Diagn Pathol","first-page":"240","article-title":"Malignant transformation of a dysembryoplastic neuroepithelial tumor after radiation and chemotherapy.","volume":"7","author":"Rushing, E. J.","year":"2003","unstructured":"Rushing, E. J., L. D.Thompson, and H.Mena. Malignant transformation of a dysembryoplastic neuroepithelial tumor after radiation and chemotherapy.Ann Diagn Pathol2003. 7:240\u2013244."},{"key":"i1543-2165-133-7-1062-b105","series-title":"Cancer","first-page":"2862","article-title":"Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis.","volume":"73","author":"Jay, V.","year":"1994","unstructured":"Jay, V., J.Squire, L. E.Becker, and R.Humphreys. Malignant transformation in a ganglioglioma with anaplastic neuronal and astrocytic components. Report of a case with flow cytometric and cytogenetic analysis.Cancer1994. 73:2862\u20132868."},{"key":"i1543-2165-133-7-1062-b106","series-title":"Clin Neurol Neurosurg","first-page":"761","article-title":"Ganglioglioma with anaplastic recurrence of the neuronal element following radiotherapy.","volume":"108","author":"Tarnaris, A.","year":"2006","unstructured":"Tarnaris, A., C.O'Brien, and R. M.Redfern. Ganglioglioma with anaplastic recurrence of the neuronal element following radiotherapy.Clin Neurol Neurosurg2006. 108:761\u2013767."},{"key":"i1543-2165-133-7-1062-b107","series-title":"Neuropathology","first-page":"463","article-title":"Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components.","volume":"27","author":"Mittelbronn, M.","year":"2007","unstructured":"Mittelbronn, M., J.Schittenhelm, and D.Lemke. et al. Low grade ganglioglioma rapidly progressing to a WHO grade IV tumor showing malignant transformation in both astroglial and neuronal cell components.Neuropathology2007. 27:463\u2013467."},{"key":"i1543-2165-133-7-1062-b108","series-title":"Pediatr Dev Pathol","first-page":"582","article-title":"Desmoplastic infantile ganglioglioma.","volume":"2","author":"Craver, R. D.","year":"1999","unstructured":"Craver, R. D., J.Nadell, and J. S.Nelson. Desmoplastic infantile ganglioglioma.Pediatr Dev Pathol1999. 2:582\u2013587."},{"key":"i1543-2165-133-7-1062-b109","series-title":"Surg Neurol","first-page":"304","article-title":"Desmoplastic infantile ganglioglioma: novel aspects in clinical presentation and genetics.","volume":"68","author":"Lonnrot, K.","year":"2007","unstructured":"Lonnrot, K., M.Terho, V.Kahara, H.Haapasalo, and P.Helen. Desmoplastic infantile ganglioglioma: novel aspects in clinical presentation and genetics.Surg Neurol2007. 68:304\u2013308."},{"key":"i1543-2165-133-7-1062-b110","series-title":"J Neurosurg Pediatrics","first-page":"95","article-title":"Desmoplastic infantile ganglioglioma with a malignant course.","volume":"1","author":"Hoving, E. W.","year":"2008","unstructured":"Hoving, E. W., J. M.Kros, E.Groninger, and W. F.den Dunnen. Desmoplastic infantile ganglioglioma with a malignant course.J Neurosurg Pediatrics2008. 1:95\u201398."},{"key":"i1543-2165-133-7-1062-b111","series-title":"Histopathology","first-page":"887","article-title":"Neuronal features of oligodendrogliomas\u2014an ultrastructural and immunohistochemical study.","volume":"50","author":"Vyberg, M.","year":"2007","unstructured":"Vyberg, M., B. P.Ulhoi, and P. S.Teglbjaerg. Neuronal features of oligodendrogliomas\u2014an ultrastructural and immunohistochemical study.Histopathology2007. 50:887\u2013896."},{"key":"i1543-2165-133-7-1062-b112","series-title":"Neuropathol Appl Neurobiol","first-page":"302","article-title":"Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study.","volume":"24","author":"Wharton, S. B.","year":"1998","unstructured":"Wharton, S. B., K. K.Chan, F. A.Hamilton, and J. R.Anderson. Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study.Neuropathol Appl Neurobiol1998. 24:302\u2013308."},{"key":"i1543-2165-133-7-1062-b113","series-title":"Acta Neuropathol","first-page":"313","article-title":"Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.","volume":"113","author":"Rodriguez, F. J.","year":"2007","unstructured":"Rodriguez, F. J., B. W.Scheithauer, and P. D.Robbins. et al. Ependymomas with neuronal differentiation: a morphologic and immunohistochemical spectrum.Acta Neuropathol2007. 113:313\u2013324."},{"key":"i1543-2165-133-7-1062-b114","series-title":"Acta Neuropathol","first-page":"194","article-title":"Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study.","volume":"89","author":"Kordek, R.","year":"1995","unstructured":"Kordek, R., W.Biernat, W.Sapieja, J.Alwasiak, and P. P.Liberski. Pleomorphic xanthoastrocytoma with a gangliomatous component: an immunohistochemical and ultrastructural study.Acta Neuropathol1995. 89:194\u2013197."},{"key":"i1543-2165-133-7-1062-b115","series-title":"Am J Surg Pathol","first-page":"80","article-title":"Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors.","volume":"20","author":"Powell, S. Z.","year":"1996","unstructured":"Powell, S. Z., A. T.Yachnis, L. B.Rorke, A. M.Rojiani, and T. A.Eskin. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors.Am J Surg Pathol1996. 20:80\u201385."},{"key":"i1543-2165-133-7-1062-b116","article-title":"Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.","author":"Perry, A.","unstructured":"Perry, A., C. R.Miller, and M.Gujrati. et al. Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.Brain Pathol. 2009;19(1):81\u201390."},{"key":"i1543-2165-133-7-1062-b117","series-title":"Virchows Arch","first-page":"665","article-title":"Secondary glioblastoma with advanced neuronal immunophenotype.","volume":"447","author":"Shibahara, J.","year":"2005","unstructured":"Shibahara, J. and M.Fukayama. Secondary glioblastoma with advanced neuronal immunophenotype.Virchows Arch2005. 447:665\u2013668."},{"key":"i1543-2165-133-7-1062-b118","series-title":"Ann Diagn Pathol","first-page":"387","article-title":"Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems.","volume":"7","author":"Vogel, H.","year":"2003","unstructured":"Vogel, H. and G. N.Fuller. Primitive neuroectodermal tumors, embryonal tumors, and other small cell and poorly differentiated malignant neoplasms of the central and peripheral nervous systems.Ann Diagn Pathol2003. 7:387\u2013398."},{"key":"i1543-2165-133-7-1062-b119","series-title":"Annu Rev Pathol","first-page":"341","article-title":"The origins of medulloblastoma subtypes.","volume":"3","author":"Gilbertson, R. J.","year":"2008","unstructured":"Gilbertson, R. J. and D. W.Ellison. The origins of medulloblastoma subtypes.Annu Rev Pathol2008. 3:341\u2013365."},{"key":"i1543-2165-133-7-1062-b120","series-title":"Nature","first-page":"436","article-title":"Prediction of central nervous system embryonal tumour outcome based on gene expression.","volume":"415","author":"Pomeroy, S. L.","year":"2002","unstructured":"Pomeroy, S. L., P.Tamayo, and M.Gaasenbeek. et al. Prediction of central nervous system embryonal tumour outcome based on gene expression.Nature2002. 415:436\u2013442."},{"key":"i1543-2165-133-7-1062-b121","series-title":"Oncol Rep","first-page":"1341","article-title":"PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.","volume":"12","author":"Inda, M. M.","year":"2004","unstructured":"Inda, M. M., J.Mercapide, and J.Munoz. et al. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.Oncol Rep2004. 12:1341\u20131347."},{"key":"i1543-2165-133-7-1062-b122","series-title":"Brain Pathol","first-page":"276","article-title":"Congenital glioblastoma: a clinicopathologic and genetic analysis.","volume":"17","author":"Brat, D. J.","year":"2007","unstructured":"Brat, D. J., B. M.Shehata, and A. A.Castellano-Sanchez. et al. Congenital glioblastoma: a clinicopathologic and genetic analysis.Brain Pathol2007. 17:276\u2013281."},{"key":"i1543-2165-133-7-1062-b123","series-title":"Expert Rev Anticancer Ther","first-page":"S51","article-title":"Spectrum of pediatric gliomas: implications for the development of future therapies.","volume":"7","author":"Pytel, P.","year":"2007","unstructured":"Pytel, P.\n          \n          Spectrum of pediatric gliomas: implications for the development of future therapies.\n          Expert Rev Anticancer Ther\n          2007. 7:S51\u2013S60."},{"key":"i1543-2165-133-7-1062-b124","series-title":"J Clin Oncol","first-page":"971","article-title":"Biologic risk stratification of medulloblastoma: the real time is now.","volume":"22","author":"Fisher, P. G.","year":"2004","unstructured":"Fisher, P. G., P. C.Burger, and C. G.Eberhart. Biologic risk stratification of medulloblastoma: the real time is now.J Clin Oncol2004. 22:971\u2013974."},{"key":"i1543-2165-133-7-1062-b125","series-title":"Neurol Clin","first-page":"897","article-title":"Pediatric brain tumors.","volume":"21","author":"Ullrich, N. J.","year":"2003","unstructured":"Ullrich, N. J. and S. L.Pomeroy. Pediatric brain tumors.Neurol Clin2003. 21:897\u2013913."},{"key":"i1543-2165-133-7-1062-b126","series-title":"J Clin Oncol","first-page":"994","article-title":"Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas.","volume":"22","author":"Fernandez-Teijeiro, A.","year":"2004","unstructured":"Fernandez-Teijeiro, A., R. A.Betensky, L. M.Sturla, J. Y.Kim, P.Tamayo, and S. L.Pomeroy. Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas.J Clin Oncol2004. 22:994\u2013998."},{"key":"i1543-2165-133-7-1062-b127","series-title":"J Clin Oncol","first-page":"984","article-title":"Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.","volume":"22","author":"Gajjar, A.","year":"2004","unstructured":"Gajjar, A., R.Hernan, and M.Kocak. et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma.J Clin Oncol2004. 22:984\u2013993."},{"key":"i1543-2165-133-7-1062-b128","series-title":"Cancer","first-page":"552","article-title":"Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.","volume":"94","author":"Eberhart, C. G.","year":"2002","unstructured":"Eberhart, C. G., J. L.Kepner, and P. T.Goldthwaite. et al. Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.Cancer2002. 94:552\u2013560."},{"key":"i1543-2165-133-7-1062-b129","series-title":"J Neuropathol Exp Neurol","first-page":"441","article-title":"Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.","volume":"63","author":"Eberhart, C. G.","year":"2004","unstructured":"Eberhart, C. G., J.Kratz, and Y.Wang. et al. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.J Neuropathol Exp Neurol2004. 63:441\u2013449."},{"key":"i1543-2165-133-7-1062-b130","series-title":"N Engl J Med","first-page":"906","article-title":"Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain.","volume":"321","author":"Biegel, J. A.","year":"1989","unstructured":"Biegel, J. A., L. B.Rorke, and B. S.Emanuel. Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain.N Engl J Med1989. 321:906."},{"key":"i1543-2165-133-7-1062-b131","series-title":"J Neurosurg","first-page":"710","article-title":"Monosomy 22 in rhabdoid or atypical tumors of the brain.","volume":"73","author":"Biegel, J. A.","year":"1990","unstructured":"Biegel, J. A., L. B.Rorke, R. J.Packer, and B. S.Emanuel. Monosomy 22 in rhabdoid or atypical tumors of the brain.J Neurosurg1990. 73:710\u2013714."},{"key":"i1543-2165-133-7-1062-b132","series-title":"Am J Surg Pathol","first-page":"1083","article-title":"Atypical teratoid\/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.","volume":"22","author":"Burger, P. C.","year":"1998","unstructured":"Burger, P. C., I. T.Yu, and T.Tihan. et al. Atypical teratoid\/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study.Am J Surg Pathol1998. 22:1083\u20131092."},{"key":"i1543-2165-133-7-1062-b133","series-title":"Ultrastruct Pathol","first-page":"369","article-title":"Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood.","volume":"21","author":"Bhattacharjee, M.","year":"1997","unstructured":"Bhattacharjee, M., J.Hicks, and L.Langford. et al. Central nervous system atypical teratoid\/rhabdoid tumors of infancy and childhood.Ultrastruct Pathol1997. 21:369\u2013378."},{"key":"i1543-2165-133-7-1062-b134","series-title":"Clin Cancer Res","first-page":"2759","article-title":"Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.","volume":"6","author":"Biegel, J. A.","year":"2000","unstructured":"Biegel, J. A., B.Fogelgren, and J. Y.Zhou. et al. Mutations of the INI1 rhabdoid tumor suppressor gene in medulloblastomas and primitive neuroectodermal tumors of the central nervous system.Clin Cancer Res2000. 6:2759\u20132763."},{"key":"i1543-2165-133-7-1062-b135","series-title":"Am J Surg Pathol","first-page":"644","article-title":"Immunohistochemical analysis of hSNF5\/INI1 in pediatric CNS neoplasms.","volume":"28","author":"Judkins, A. R.","year":"2004","unstructured":"Judkins, A. R., J.Mauger, A.Ht, L. B.Rorke, and J. A.Biegel. Immunohistochemical analysis of hSNF5\/INI1 in pediatric CNS neoplasms.Am J Surg Pathol2004. 28:644\u2013650."},{"key":"i1543-2165-133-7-1062-b136","series-title":"Expert Rev Anticancer Ther","first-page":"907","article-title":"Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges.","volume":"5","author":"Strother, D.","year":"2005","unstructured":"Strother, D.\n          \n          Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges.\n          Expert Rev Anticancer Ther\n          2005. 5:907\u2013915."},{"key":"i1543-2165-133-7-1062-b137","series-title":"Diagn Mol Pathol","first-page":"108","article-title":"Primary Ewing sarcoma of the brain: a case report and literature review.","volume":"16","author":"Kazmi, S. A.","year":"2007","unstructured":"Kazmi, S. A., A.Perry, J. G.Pressey, J. C.Wellons, Y.Hammers, and C. A.Palmer. Primary Ewing sarcoma of the brain: a case report and literature review.Diagn Mol Pathol2007. 16:108\u2013111."},{"key":"i1543-2165-133-7-1062-b138","series-title":"Hum Pathol","first-page":"845","article-title":"Peripheral primitive neuroectodermal tumor\/Ewing's sarcoma of the craniospinal vault: case reports and review.","volume":"37","author":"Mobley, B. C.","year":"2006","unstructured":"Mobley, B. C., D.Roulston, G. V.Shah, K. E.Bijwaard, and P. E.McKeever. Peripheral primitive neuroectodermal tumor\/Ewing's sarcoma of the craniospinal vault: case reports and review.Hum Pathol2006. 37:845\u2013853."},{"key":"i1543-2165-133-7-1062-b139","series-title":"J Neurooncol","first-page":"65","article-title":"Primitive neuroectodermal tumours (PNETs) located in the spinal canal; the relevance of classification as central or peripheral PNET: case report of a primary spinal PNET occurrence with a critical literature review.","volume":"77","author":"Kampman, W. A.","year":"2006","unstructured":"Kampman, W. A., J. M.Kros, T. H.De Jong, and M. H.Lequin. Primitive neuroectodermal tumours (PNETs) located in the spinal canal; the relevance of classification as central or peripheral PNET: case report of a primary spinal PNET occurrence with a critical literature review.J Neurooncol2006. 77:65\u201372."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/133\/7\/article-p1062.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/133\/7\/1062\/2767931\/1543-2165-133_7_1062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/133\/7\/article-p1062.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/133\/7\/article-p1062.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:06:10Z","timestamp":1770771970000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/133\/7\/article-p1062.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":278,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.5858\/133.7.1062","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}